haloperidol has been researched along with Affective Psychosis, Bipolar in 346 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of ketamine for depression has increased rapidly in the past decades." | 9.12 | Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review. ( Bakker, IM; Kamphuis, J; Schoevers, RA; Smith-Apeldoorn, SY; Touw, DJ; Veraart, JKE; Visser, BAE, 2021) |
| "The objective of this article is to assess the clinical characteristics of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder receiving aripiprazole, haloperidol, olanzapine, or placebo." | 8.86 | Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. ( Assunção-Talbott, S; Barnes, TR; Buckley, P; Correll, CU; Eudicone, J; Kane, JM; McQuade, R; Pikalov, A; Sachs, G; Tran, QV, 2010) |
| "Consistent with prior research, haloperidol-treated patients with bipolar disorder appeared to be more vulnerable to the development of EPS than those with schizophrenia." | 8.83 | Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials. ( Berg, PH; Briggs, SD; Cavazzoni, PA; Kane, JM; Kryzhanovskaya, LA; Roddy, TE; Tohen, M, 2006) |
| "A nondiabetic young male patient in hypomanic phase of bipolar disorder on maintenance treatment with sodium valproate, developed transient episode of acute pancreatitis and diabetic ketoacidosis after addition of chlorpromazine and halopridol." | 7.72 | Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol. ( Gupta, SB; Laghate, VD, 2004) |
| "A 37-year-old woman with cerebral palsy and a rapid cycling bipolar affective disorder developed drowsiness and slurred speech when being treated with a combination of haloperidol and a low dose of carbamazepine." | 7.67 | An interaction between haloperidol and carbamazepine in a patient with cerebral palsy. ( Brayley, J; Yellowlees, P, 1987) |
| "In an open study, 18 patients suffering from an acute episode of schizophrenia and 18 patients with severe mania were given haloperidol at different dosage levels." | 7.67 | Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia. ( Balant, L; Balant-Gorgia, AE; Eisele, R; Garrone, G, 1984) |
| "Reported is a 19-year-old manic-depressive patient who developed persistent dysarthria with coexisting apraxia while on a combination of high dose haloperidol and lithium carbonate." | 7.66 | Persistent dysarthria with apraxia associated with a combination of lithium carbonate and haloperidol. ( Bond, WS; Carvalho, M; Foulks, EF, 1982) |
| "A case of neuroleptic malignant syndrome (NMS) with an abrupt onset was terminated quickly with i." | 5.27 | Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. ( Jaffe, JH; Khan, A; Morrison, B; Nelson, WH, 1985) |
| "All medications produced a calming effect within one hour of administration, but only olanzapine and haloperidol reduced agitation by less than 10 points, and only olanzapine reduced aggression by less than four points in the first hour." | 5.15 | Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone. ( Baldaçara, L; Cordeiro, DC; Jackoswski, AP; Sanches, M, 2011) |
| " Forty-five hospitalized patients with moderate-to-severe manic, bipolar disorder (DSM-IV) were randomly assigned to a zotepine or a haloperidol 4-week treatment group." | 5.14 | A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania. ( Chan, HY; Chang, CJ; Chen, CH; Chen, JJ; Chiu, NY; Jou, SH; Juang, YY, 2010) |
| "The use of ketamine for depression has increased rapidly in the past decades." | 5.12 | Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review. ( Bakker, IM; Kamphuis, J; Schoevers, RA; Smith-Apeldoorn, SY; Touw, DJ; Veraart, JKE; Visser, BAE, 2021) |
| "Open-label olanzapine treatment for 6 months was associated with improvements in work functional outcomes in patients with bipolar disorder." | 5.12 | Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes. ( Edgell, ET; Hackworth, J; Haro, JM; Juarez, R; Shi, L; Tohen, MF; Vieta, E, 2006) |
| "The effects of haloperidol, risperidone, and thioridazine on the pharmacokinetics and side-effect profile of quetiapine were investigated in 36 patients with schizophrenia, schizoaffective disorder, or bipolar disorder in a single-center, two-period, multiple-dose, open-label, randomized trial." | 5.10 | The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine. ( Alva, G; Arvanitis, LA; Bera, R; Potkin, SG; Thyrum, PT; Yeh, C, 2002) |
| " In 3 double-blind studies, acutely agitated patients with schizophrenia (N = 311), bipolar mania (N = 201), or dementia (N = 206) were treated with intramuscular (1-3 injections/24 hrs) olanzapine (2." | 5.10 | Calming versus sedative effects of intramuscular olanzapine in agitated patients. ( Alaka, K; Battaglia, J; Lindborg, SR; Meehan, K; Wright, P, 2003) |
| "We aimed to compare clinical outcomes, health-related quality of life (HRQOL) and work status associated with olanzapine and haloperidol treatment in patients with bipolar disorder." | 5.10 | Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. ( Breier, A; Edgell, ET; Gandhi, G; Haro, JM; Namjoshi, MA; Shi, L; Tohen, M; Zhang, F, 2002) |
| "This 3-week randomized, double-blind, placebo-controlled study included 156 bipolar disorder patients with a current manic or mixed episode who received a mood stabilizer (lithium or divalproex) and placebo, risperidone, or haloperidol." | 5.10 | Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. ( Bowden, CL; Ghaemi, SN; Grossman, F; Okamoto, A; Sachs, GS, 2002) |
| "The efficacy of ritanserin to obtain a better improvement in patients with mania seems to support the 5-HT hypothesis of bipolar disorder." | 5.10 | Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial. ( Akhondzadeh, S; Amini, H; Mohajari, H; Reza Mohammadi, M, 2003) |
| " Databases included: placebo-controlled [two schizophrenia, one bipolar mania trials (n=565)]; haloperidol-controlled [two schizophrenia trials (n=482)]; geriatric placebo-controlled [1 dementia trial (n=204)]." | 5.10 | Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients. ( Alaka, K; Beasley, CM; Lindborg, SR; Taylor, CC, 2003) |
| "Thirty-one consenting acute inpatient subjects between ages 19 and 66 years with a DSM-III-R clinical diagnosis of bipolar disorder, manic with psychotic features were entered into this double-blind study and were randomly assigned to receive either haloperidol 25 mg/day or haloperidol 5 mg for the 3-week study." | 5.09 | Pretreatment plasma HVA and haloperidol response in acute mania. ( Bebe, R; Chang, WH; Charles, O; Chou, JC; Cooper, TB; Czobor, P; Lane, HY; Stone, DL; Tuma, I, 2000) |
| "After a < or = 1-day screening period, 36 consecutive hospitalized patients with bipolar disorder, manic or mixed phase and with psychotic features, were randomly assigned to receive either divalproex 20 mg/kg/day or haloperidol 0." | 5.08 | A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. ( Bennett, JA; Keck, PE; McElroy, SL; Stanton, SP; Strakowski, SM; Tugrul, KC, 1996) |
| "We now present data from a randomized, double-blind clinical study of lorazepam versus haloperidol in 20 hospitalized patients with a DSM-III-R diagnosis of bipolar disorder who were being treated concomitantly with lithium." | 5.07 | Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. ( Creelman, WL; Lenox, RH; Newhouse, PA; Whitaker, TM, 1992) |
| " The first group (n = 120) suffered from schizophrenia and was treated only with haloperidol." | 5.07 | Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients. ( Aizenberg, D; Hermesh, H; Lapidot, M; Mayor, C; Munitz, H; Weizman, A, 1992) |
| "Treatment of acute mania with second-generation antipsychotics has been claimed to involve a lower risk of switch to depression than haloperidol." | 4.89 | Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. ( Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E, 2013) |
| "The objective of this article is to assess the clinical characteristics of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder receiving aripiprazole, haloperidol, olanzapine, or placebo." | 4.86 | Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. ( Assunção-Talbott, S; Barnes, TR; Buckley, P; Correll, CU; Eudicone, J; Kane, JM; McQuade, R; Pikalov, A; Sachs, G; Tran, QV, 2010) |
| "Consistent with prior research, haloperidol-treated patients with bipolar disorder appeared to be more vulnerable to the development of EPS than those with schizophrenia." | 4.83 | Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials. ( Berg, PH; Briggs, SD; Cavazzoni, PA; Kane, JM; Kryzhanovskaya, LA; Roddy, TE; Tohen, M, 2006) |
| "Randomised trials comparing haloperidol with placebo or other active treatment in the treatment of acute manic or mixed episodes in patients with bipolar disorder or schizoaffective disorder." | 4.83 | Haloperidol alone or in combination for acute mania. ( Cipriani, A; Geddes, JR; Rendell, JM, 2006) |
| "Lithium carbonate is the single most important long-term treatment for recurrent affective disorders." | 4.76 | Lithium. ( DePaulo, JR, 1984) |
| "Over 67 days, 1,461 patients were screened in the ED, 269 had bipolar I or schizophrenia, 194 of whom had a contraindication to inhaled loxapine leaving 75 eligible patients; preconsent was obtained in 43 patients." | 3.91 | Study Enrollment When "Preconsent" Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department. ( Cole, JB; Driver, BE; Klein, LR; Mullinax, SZ; Nordstrom, KD; Wilson, MP, 2019) |
| "A patient with bipolar I disorder has been treated with lithium and haloperidol for the last 20 years and received an ACE inhibitor for his hypertension since 9 years ago." | 3.85 | Hypertensive bipolar: chronic lithium toxicity in patients taking ACE inhibitor. ( Abdul Aziz, MF; Masiran, R, 2017) |
| "Asenapine is a novel psychopharmacologic agent under development for the treatment of schizophrenia and bipolar disorder." | 3.75 | Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. ( Shahid, M; Walker, GB; Wong, EH; Zorn, SH, 2009) |
| "To compare the effectiveness of intramuscular (IM) olanzapine and typical IM antipsychotics in naturalistically treated acutely agitated patients with schizophrenia or acute mania." | 3.75 | Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation. ( Castle, DJ; Isik, T; Karagianis, J; Kim, CY; Melamed, Y; Omar, AN; Pidrman, V; Rosales, JI; Sarosi, A; Treuer, T; Udristoiu, T, 2009) |
| "Analysis 1 found that nonsedated patients with bipolar I disorder and schizophrenia showed significant decreases in PEC scores following treatment with aripiprazole IM (p < 0." | 3.74 | Intramuscular aripiprazole in the control of agitation. ( Citrome, LL; Crandall, DT; Currier, GW; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL, 2007) |
| " The initial doses varied widely, ranging from 1 to 30 mg, with a maximum total daily dosage of 100 mg." | 3.74 | Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol. ( Donlon, PT; Hopkin, J; Tupin, JP, 1979) |
| " We report on a young Chinese man with bipolar disorder who developed TD after haloperidol treatment, involving the trunk, limbs, and orofacial area." | 3.73 | A blessing in disguise: resolution of tardive dyskinesia with development of cervical myelitis. ( Lim, EC; Seet, RC; Wilder-Smith, EP, 2006) |
| " In a first genome scan on obesity under antipsychotics in SZ and BP, we analyzed 21 multigenerational kindreds (508 family members) including several patients treated for a minimum of 3 years mainly with haloperidol or chlopromazine." | 3.72 | A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses. ( Bouchard, RH; Chagnon, YC; Emond, C; Maziade, M; Mérette, C; Roy, MA, 2004) |
| "A nondiabetic young male patient in hypomanic phase of bipolar disorder on maintenance treatment with sodium valproate, developed transient episode of acute pancreatitis and diabetic ketoacidosis after addition of chlorpromazine and halopridol." | 3.72 | Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol. ( Gupta, SB; Laghate, VD, 2004) |
| "Patients displaying a moderate-to-marked response to olanzapine were more likely to be younger; be female; receive a diagnosis of bipolar disorder; and have a shorter duration of illness, shorter length of stay prior to olanzapine, and longer duration of trial." | 3.70 | Clinical predictors of acute response with olanzapine in psychotic mood disorders. ( Berman, A; Greaney, JJ; Madrid, A; Narendran, R; Pike, S; Tohen, M; Zarate, CA, 1998) |
| " Thirty-six acutely psychotic patients receiving parenteral haloperidol were evaluated by the Brief Psychiatric Rating Scale, the Schedule for Affective Disorders and Schizophrenia-Change Version, and the Nurses' Observation Scale for Inpatient Evaluation, as well as by drug levels in plasma." | 3.68 | Acutely psychotic patients receiving high-dose haloperidol therapy. ( Coulter, K; Pollock, B; Reed, K; Remington, G; Voineskos, G, 1993) |
| " Many such patients respond to a trial of lithium therapy; responders are usually better able to work or attend school and to live independently, and they less often show the degree of personality deterioration present in classical schizophrenia." | 3.67 | Acutely psychotic patients: a treatment approach. ( Cade, JR; Lippmann, S; Wagemaker, H, 1985) |
| "A 37-year-old woman with cerebral palsy and a rapid cycling bipolar affective disorder developed drowsiness and slurred speech when being treated with a combination of haloperidol and a low dose of carbamazepine." | 3.67 | An interaction between haloperidol and carbamazepine in a patient with cerebral palsy. ( Brayley, J; Yellowlees, P, 1987) |
| "A 52-year-old woman with bipolar disorder, rapid-cycling type, developed delirium while taking therapeutic doses of carbamazepine and neuroleptics." | 3.67 | Case report of a possible interaction between neuroleptics and carbamazepine. ( Ciccone, JR; Kanter, GL; Yerevanian, BI, 1984) |
| "In an open study, 18 patients suffering from an acute episode of schizophrenia and 18 patients with severe mania were given haloperidol at different dosage levels." | 3.67 | Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia. ( Balant, L; Balant-Gorgia, AE; Eisele, R; Garrone, G, 1984) |
| "Combined treatment with haloperidol and lithium is a frequently employed strategy for the treatment of acute psychoses." | 3.66 | Effect of combined haloperidol-lithium treatment on vitro RBC lithium uptake in patients with affective disorders. ( Grof, P; Rotstein, E; Werner, L; Werstiuk, ES, 1983) |
| "Baclofen, commonly used to reduce severe muscle spasms in patients with spinal cord injuries, is also active in the brain." | 3.66 | A possible neurochemical basis for the neuropsychiatric aspects of baclofen therapy. ( Keegan, DL; Kirby, AR; Richardson, JS, 1983) |
| "Reported is a 19-year-old manic-depressive patient who developed persistent dysarthria with coexisting apraxia while on a combination of high dose haloperidol and lithium carbonate." | 3.66 | Persistent dysarthria with apraxia associated with a combination of lithium carbonate and haloperidol. ( Bond, WS; Carvalho, M; Foulks, EF, 1982) |
| "The authors describe a case of combined lithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of irreversible tardive dyskinesia." | 3.66 | New data on lithium and haloperidol incompatibility. ( Frankel, M; Spring, G, 1981) |
| "A report is made on two cases of a pharmacogenic delirium as a result of combined lithium-haloperidol therapy, and on one case of lithium-induced diabetes insipidus renales with second-degree high pressure." | 3.65 | [Dangerous side effects of lithium therapy]. ( Ehle, G; Uebelhack, R, 1977) |
| "Haloperidol was found to be significantly more efficacious in the reduction of the mania scale score at week 1." | 2.78 | Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania. ( Capapey, J; Colom, F; Goikolea, JM; Grande, I; Torres, I; Undurraga, J; Valenti, M; Vieta, E, 2013) |
| " Safety measures included treatment-emergent adverse events (TEAEs), weight and extrapyramidal symptoms (EPSs)." | 2.77 | Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study. ( Higuchi, T; Kanba, S; Katagiri, H; Takahashi, M; Takita, Y; Tohen, M, 2012) |
| "Risperidone was shown to have significant anti-manic effects which was observed as early as week 1, following start of treatment." | 2.77 | Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania. ( Hsu, MC; Kuo, CC; Ouyang, WC; Yeh, IN, 2012) |
| "Ziprasidone was shown to be effective monotherapy for acute treatment of bipolar mania." | 2.75 | Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study. ( English, PA; Keller, D; Loebel, AD; Miceli, J; Ramey, T; Vieta, E, 2010) |
| "Aripiprazole was well tolerated." | 2.74 | Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. ( Carson, WH; Lowy, A; Marcus, RN; McQuade, RD; Oren, DA; Sanchez, R; Spiller, NH; Torbeyns, AF; Young, AH, 2009) |
| "Patients (n=302) with bipolar I disorder (manic episode) were randomised to 12 weeks' double-blind treatment with quetiapine (flexibly dosed up to 800 mg/day), placebo, or haloperidol (up to 8 mg/day)." | 2.71 | Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. ( Brecher, M; Huizar, K; McIntyre, RS; Mullen, J; Paulsson, B, 2005) |
| "The design consisted of 2 successive, 6-week, double-blind periods and compared flexible dosing of olanzapine (5-20 mg/d, n = 234) with haloperidol (3-15 mg/d, n = 219)." | 2.71 | A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. ( Azorin, JM; Baker, RW; Breier, A; Emsley, RA; Evans, AR; Goldberg, JF; Gonzalez-Pinto Arrillaga, AM; Hardy-Bayle, MC; Lawson, WB; Namjoshi, MA; Risser, RC; Tohen, M; Vieta, E; Zhang, F, 2003) |
| "Patients with schizoaffective disorder bipolar type, characterized as currently manic, mixed, depressed, or euthymic, were assessed weekly for 6 weeks during treatment with either olanzapine or haloperidol." | 2.70 | Olanzapine versus haloperidol in schizoaffective disorder, bipolar type. ( Breier, A; Feldman, PD; Keck, PE; Risser, RC; Tohen, M; Tran, PV; Zhang, F, 2001) |
| " Haloperidol blood levels may be clinically useful in identifying patients who are nonresponsive because of low drug levels and, hence, in enhancing optimal haloperidol dosing for acute mania with psychosis." | 2.70 | Haloperidol blood levels in acute mania with psychosis. ( Chou, JC; Cooper, TB; Czobor, P; Dacpano, G; Richardson, N; Trujillo, M; Tuma, I; Volavka, J, 2001) |
| "Lorazepam 4 mg/day was insufficient to produce an advantage when added to low-dose haloperidol." | 2.69 | Acute mania: haloperidol dose and augmentation with lithium or lorazepam. ( Allen, MH; Charles, O; Chou, JC; Czobor, P; Trujillo, M; Tuma, I; Volavka, J; Winsberg, B, 1999) |
| "clonazepam is an effective, safe, but slower-acting alternative to I." | 2.67 | A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. ( Annable, L; Chouinard, G; Holobow, N; Szkrumelak, N; Turnier, L, 1993) |
| "Clonazepam was found to be significantly more efficacious than lithium in reducing manic symptoms despite the fact that during clonazepam treatment less patients required PRNs of haloperidol." | 2.65 | Antimanic effect of clonazepam. ( Annable, L; Chouinard, G; Young, SN, 1983) |
| "Carbamazepine has recently been reported to have therapeutic potential in mania." | 2.65 | Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study. ( Belmaker, RH; Bental, E; Klein, E; Lerer, B, 1984) |
| " Overall, 25 years of experience have indicated that haloperidol can be used safely and effectively to manage a variety of psychiatric illnesses, so long as dosage and method of administration are adjusted to individual patients' needs." | 2.65 | Haloperidol: a quarter century of experience. ( Ayd, FJ; Settle, EC, 1983) |
| " Mean daily dosage was approximately 112 mg flupenthixol and 18 mg haloperidol." | 2.65 | Flupenthixol versus haloperidol in acute psychosis. ( Parent, M; Toussaint, C, 1983) |
| " Renal dosing for topiramate, reduction in PIMs/anticholinergic burden, and substituting haloperidol for olanzapine resolved his violent behavior and CD." | 2.50 | Capgras delusion with violent behavior in Alzheimer dementia: case analysis with literature review. ( Dawood, A; Kaufman, KR; Newman, NB, 2014) |
| "Aripiprazole is an effective treatment for mania in a population that includes adults, children and adolescents, although its use leads to gastrointestinal disturbances and movement disorders." | 2.49 | Aripiprazole alone or in combination for acute mania. ( Brown, R; Geddes, J; Taylor, MJ, 2013) |
| "Ten acute trials in mania, 3 in bipolar depression, and 8 in schizophrenia were identified, along with 2 maintenance studies in bipolar disorder and 2 in schizophrenia." | 2.44 | A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. ( Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ, 2008) |
| "Haloperidol was superior to quetiapine in efficacy at day 21 but similar at day 84." | 2.44 | Quetiapine for acute mania in bipolar disorder. ( Brahm, NC; Carnahan, RM; Gutierres, SL, 2007) |
| "Risperidone monotherapy was more effective than placebo in reducing manic symptoms, using the Young Mania Rating Scale (YMRS) (weighted mean difference (WMD) -5." | 2.43 | Risperidone alone or in combination for acute mania. ( Bauer, MS; Geddes, GR; Gijsman, HJ; Goodwin, GM; Rendell, JM, 2006) |
| "Two patients with akathisia developing only after neuroleptic dosage reduction or withdrawal are described." | 2.39 | Withdrawal akathisia: case reports and a proposed classification of chronic akathisia. ( Lang, AE, 1994) |
| "Acute fixed cervical kyphosis may be a rare presentation of conversion disorder, psychogenic dystonia, and potentially as a side effect from typical antipsychotic drugs." | 1.46 | An unusual cause of cervical kyphosis. ( Raj, MS; Schwab, JH, 2017) |
| " The aim of this research is to estimate the influence of lithium (alone and in combination with haloperidol) on the parameters of oxidative stress and viability of SH-SY5Y cell lines in neutral and pro-oxidative conditions." | 1.43 | Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture. ( Gawlik-Kotelnicka, O; Lazarek, J; Mielicki, W; Rabe-Jabłońska, J; Strzelecki, D, 2016) |
| "Co-morbid substance abuse was uncommon." | 1.39 | Prevalence and clinical presentation of HIV positive female psychiatric inpatients. ( Uys, H, 2013) |
| "Rodent models offer a tractable system to test this hypothesis, and we therefore examined the effect of chronic treatment (8 weeks) and subsequent withdrawal (8 weeks) with clinically relevant dosing of an antipsychotic (haloperidol, HAL) or lithium (Li) on brain volume using longitudinal in vivo structural MRI and confirmed the findings postmortem using unbiased stereology." | 1.38 | Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. ( Cooper, JD; Crum, WR; Kapur, S; Modo, M; Natesan, S; Vernon, AC; Williams, SC, 2012) |
| " We found substantial differences in baseline characteristics of subjects, administered dosage and disease severity in India compared to the USA and Russia." | 1.37 | Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study. ( Lombardo, I; Mandel, FS; Pappadopulos, E; Vieta, E, 2011) |
| " Chronic administration of typical antipsychotics induced a significant upregulation of A2A AR binding sites." | 1.33 | Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics. ( Alessio, L; Bianchi, M; Cassano, GB; Catena, M; Cerrai, E; Ciapparelli, A; Dell'Osso, L; Lucacchini, A; Martini, C; Novelli, L; Trincavelli, ML; Tuscano, D, 2006) |
| "Thus it is necessary to rule out ictal catatonia by electroencephalography in patients with catatonic stupor." | 1.33 | Epileptic seizures superimposed on catatonic stupor. ( Awata, S; Ebina, Y; Honda, T; Matsuoka, H; Miura, N; Shindo, T; Suzuki, K; Takano, T, 2006) |
| " The reduction of CD151 mRNA levels was also observed following chronic administration of carbamazepine and valproate." | 1.31 | Tetraspan protein CD151: a common target of mood stabilizing drugs? ( Green, M; Hua, LV; Li, PP; Warsh, JJ; Wong, A, 2001) |
| "The delirium was reversible when all drugs were stopped; however, dyskinesia was found to be persistent after a period of 6 months." | 1.30 | Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction. ( Berger, M; Brandt, C; Normann, C; Walden, J, 1998) |
| "A 48-year-old, right-handed man had a cerebral infarct over the left temporal region." | 1.29 | Bipolar disorder following a stroke involving the left hemisphere. ( Fuh, JL; Liu, CY; Liu, HC; Wang, SJ; Yang, YY, 1996) |
| "The relationship between NMS and catatonia and possible therapeutic decisions are discussed." | 1.29 | Neuroleptic malignant syndrome and catatonia. A report of three cases. ( Altavista, MC; Cavallari, S; Lubich, L; Raja, M, 1994) |
| "Treatment with haloperidol and lithium was unsuccessful but the addition of carbamazepine produced a dramatic response." | 1.29 | A patient with mania and photoconvulsive epilepsy. ( Corbett, AJ; Reid, WG; Roxanas, MG, 1996) |
| " There was no significant difference in Li dosage among these three groups." | 1.28 | Effect of lithium and neuroleptic combination on lithium transport, blood pressure, and weight in bipolar patients. ( Ghadirian, AM; Nair, NP; Schwartz, G, 1989) |
| "A case of neuroleptic malignant syndrome is described in a 37-year-old man with mental retardation, hypomania and a history of recent hepatitis B infection." | 1.28 | Neuroleptic malignant syndrome with hypomania and mental retardation. ( Corbett, JA; Ward, MR, 1989) |
| " Evidence for this is based on the fact that in our patients and others mentioned in the literature the dosage and blood levels of lithium were not high." | 1.27 | Toxic irreversible encephalopathy induced by lithium carbonate and haloperidol. A report of 2 cases. ( Hurwitz, MD; Sandyk, R, 1983) |
| "Twenty-nine patients were treated with haloperidol decanoate, the dosage ranging from 100 to 300 mg i." | 1.27 | The use of depot neuroleptic haloperidol decanoate. ( Fernando, J; Jones, GG; Krishna Raju, R; Stanley, RO, 1984) |
| "The authors studied high-potency versus low-potency neuroleptic dosing practices for 110 Boston-area psychiatric inpatients and compared the findings with the dosing practices reported in surveys of nearly 16,000 Veterans Administration patients." | 1.27 | Dissimilar dosing with high-potency and low-potency neuroleptics. ( Baldessarini, RJ; Cotton, P; Katz, B, 1984) |
| " The results counter sporadic clinical reports suggesting a toxic interaction between lithium and neuroleptic drugs." | 1.27 | Safety of the combination of lithium and neuroleptic drugs. ( Goldney, RD; Spence, ND, 1986) |
| " An increase in dosage also had only a transient effect." | 1.27 | Development of tolerance to the therapeutic effect of amantadine on akathisia. ( Barreira, P; Lipinski, JF; Zubenko, GS, 1984) |
| "A case of neuroleptic malignant syndrome (NMS) with an abrupt onset was terminated quickly with i." | 1.27 | Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. ( Jaffe, JH; Khan, A; Morrison, B; Nelson, WH, 1985) |
| "Haloperidol pretreatment in one pair of twins abolished the excitation response but did not reduce increases in cortisol and growth hormone." | 1.26 | Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients. ( Brown, GM; Dibble, ED; Ebert, M; Gershon, ES; Gold, P; Guroff, JJ; Jimerson, DC; Jimerson, SS; Kessler, LR; Nurnberger, JI; Simmons, S; Storch, FI, 1982) |
| "These episodes are differentiated from nocturnal wanderings and epileptic attacks during sleep; they occurred within two to three hours after sleep onset and were characterized by the patients appearing confused and walking about in a quiet, detached and clumsy manner." | 1.26 | Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment. ( Charney, DS; Kales, A; Nelson, JC; Soldatos, CR, 1979) |
| "The TSH response in the groups with reactive depression, reactive paranoid psychosis, and neurotic depression, respectively, did not differ significantly from that found in controls." | 1.26 | Thyrotrophin-releasing hormone (TRH) stimulation test in manic-depressive illness. ( Bjørum, N; Cohn, D; Kirkegaard, C; Lauridsen, UB, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 166 (47.98) | 18.7374 |
| 1990's | 63 (18.21) | 18.2507 |
| 2000's | 72 (20.81) | 29.6817 |
| 2010's | 41 (11.85) | 24.3611 |
| 2020's | 4 (1.16) | 2.80 |
| Authors | Studies |
|---|---|
| Shahid, M | 1 |
| Walker, GB | 1 |
| Zorn, SH | 1 |
| Wong, EH | 1 |
| Kishi, T | 1 |
| Ikuta, T | 1 |
| Matsuda, Y | 1 |
| Sakuma, K | 1 |
| Okuya, M | 1 |
| Nomura, I | 1 |
| Hatano, M | 1 |
| Iwata, N | 1 |
| Yu, CL | 1 |
| Carvalho, AF | 1 |
| Thompson, T | 1 |
| Tsai, TC | 1 |
| Tseng, PT | 1 |
| Hsu, CW | 1 |
| Hsu, TW | 1 |
| Liang, CS | 1 |
| Abaatyo, J | 1 |
| Favina, A | 1 |
| Kaggwa, MM | 1 |
| Veraart, JKE | 1 |
| Smith-Apeldoorn, SY | 1 |
| Bakker, IM | 1 |
| Visser, BAE | 1 |
| Kamphuis, J | 1 |
| Schoevers, RA | 1 |
| Touw, DJ | 1 |
| Buoli, M | 1 |
| Esposito, CM | 1 |
| Godio, M | 1 |
| Caldiroli, A | 1 |
| Serati, M | 1 |
| Altamura, AC | 1 |
| Masiran, R | 1 |
| Abdul Aziz, MF | 1 |
| Rask, O | 1 |
| Suneson, K | 1 |
| Holmström, E | 1 |
| Bäckström, B | 1 |
| Johansson, BA | 1 |
| Cole, JB | 1 |
| Klein, LR | 1 |
| Mullinax, SZ | 1 |
| Nordstrom, KD | 1 |
| Driver, BE | 1 |
| Wilson, MP | 1 |
| Uys, H | 1 |
| Horiuchi, Y | 1 |
| Ishikawa, M | 1 |
| Kaito, N | 1 |
| Iijima, Y | 1 |
| Tanabe, Y | 1 |
| Ishiguro, H | 1 |
| Arinami, T | 1 |
| Emul, M | 4 |
| Karamustafalioglu, N | 4 |
| Kalelioglu, T | 4 |
| Genc, A | 4 |
| Tasdemir, A | 4 |
| Gungor, FC | 2 |
| Incir, S | 4 |
| Seven, A | 1 |
| Brown, R | 1 |
| Taylor, MJ | 1 |
| Geddes, J | 1 |
| Can Gungor, F | 1 |
| Cansiz, A | 1 |
| Cem Ilnem, M | 1 |
| Kaufman, KR | 1 |
| Newman, NB | 1 |
| Dawood, A | 1 |
| Konopaske, GT | 1 |
| Lange, N | 1 |
| Coyle, JT | 1 |
| Benes, FM | 1 |
| Genc, ES | 1 |
| Ilnem, C | 1 |
| Umut, G | 1 |
| Akkuş, M | 1 |
| Udawela, M | 1 |
| Money, TT | 1 |
| Neo, J | 1 |
| Seo, MS | 1 |
| Scarr, E | 2 |
| Dean, B | 2 |
| Everall, IP | 1 |
| Gawlik-Kotelnicka, O | 1 |
| Mielicki, W | 1 |
| Rabe-Jabłońska, J | 1 |
| Lazarek, J | 1 |
| Strzelecki, D | 1 |
| Fabrazzo, M | 1 |
| Monteleone, P | 1 |
| Prisco, V | 1 |
| Perris, F | 1 |
| Catapano, F | 1 |
| Tortorella, A | 1 |
| Monteleone, AM | 1 |
| Steardo, L | 1 |
| Maj, M | 1 |
| Mörkl, S | 1 |
| Blesl, C | 1 |
| Wurm, WE | 1 |
| Tmava, A | 1 |
| Rasmussen, SA | 1 |
| Rosebush, PI | 1 |
| Anglin, RE | 1 |
| Mazurek, MF | 1 |
| Raj, MS | 1 |
| Schwab, JH | 1 |
| dos Santos, A | 1 |
| da Silva, JA | 1 |
| Almeida, J | 1 |
| Corrêa, BB | 1 |
| Gago, J | 1 |
| Xavier, M | 1 |
| Vieta, E | 10 |
| Ramey, T | 1 |
| Keller, D | 1 |
| English, PA | 1 |
| Loebel, AD | 2 |
| Miceli, J | 1 |
| Young, AH | 1 |
| Oren, DA | 1 |
| Lowy, A | 1 |
| McQuade, RD | 1 |
| Marcus, RN | 1 |
| Carson, WH | 1 |
| Spiller, NH | 1 |
| Torbeyns, AF | 1 |
| Sanchez, R | 2 |
| Castle, DJ | 1 |
| Udristoiu, T | 1 |
| Kim, CY | 1 |
| Sarosi, A | 1 |
| Pidrman, V | 1 |
| Omar, AN | 1 |
| Rosales, JI | 1 |
| Melamed, Y | 1 |
| Isik, T | 1 |
| Karagianis, J | 1 |
| Treuer, T | 1 |
| English, JA | 2 |
| Dicker, P | 2 |
| Föcking, M | 2 |
| Dunn, MJ | 2 |
| Cotter, DR | 2 |
| Harvey, PD | 1 |
| Endicott, JM | 1 |
| Uezato, A | 1 |
| Meador-Woodruff, JH | 1 |
| McCullumsmith, RE | 1 |
| Kane, JM | 3 |
| Barnes, TR | 1 |
| Correll, CU | 2 |
| Sachs, G | 1 |
| Buckley, P | 1 |
| Eudicone, J | 1 |
| McQuade, R | 3 |
| Tran, QV | 1 |
| Pikalov, A | 1 |
| Assunção-Talbott, S | 1 |
| Sekhar, S | 1 |
| Kalra, B | 1 |
| Mendhekar, DN | 2 |
| Tekur, U | 1 |
| Zivković, M | 1 |
| Mihaljević-Peles, A | 1 |
| Sagud, M | 1 |
| Silić, A | 1 |
| Mihanović, M | 1 |
| Sheridan, EM | 1 |
| DelBello, MP | 1 |
| Chan, HY | 1 |
| Jou, SH | 1 |
| Juang, YY | 1 |
| Chang, CJ | 1 |
| Chen, JJ | 1 |
| Chen, CH | 1 |
| Chiu, NY | 1 |
| Rabasseda, X | 1 |
| Preskorn, SH | 1 |
| Pappadopulos, E | 1 |
| Mandel, FS | 1 |
| Lombardo, I | 1 |
| Schubert, KO | 1 |
| Baldaçara, L | 1 |
| Sanches, M | 1 |
| Cordeiro, DC | 1 |
| Jackoswski, AP | 1 |
| Mukherji, EH | 1 |
| Bauer, LK | 1 |
| Leskov, I | 1 |
| Januzzi, JL | 1 |
| Tanev, KS | 1 |
| Katagiri, H | 1 |
| Takita, Y | 1 |
| Tohen, M | 8 |
| Higuchi, T | 1 |
| Kanba, S | 1 |
| Takahashi, M | 1 |
| Vernon, AC | 1 |
| Natesan, S | 1 |
| Crum, WR | 1 |
| Cooper, JD | 1 |
| Modo, M | 1 |
| Williams, SC | 1 |
| Kapur, S | 1 |
| Ouyang, WC | 1 |
| Hsu, MC | 1 |
| Yeh, IN | 1 |
| Kuo, CC | 1 |
| Ulhaq, I | 1 |
| Abba-Aji, A | 1 |
| Ellis, LD | 1 |
| Soanes, KH | 1 |
| Catanesi, R | 1 |
| Carabellese, F | 1 |
| La Tegola, D | 1 |
| Alfarano, E | 1 |
| Goikolea, JM | 2 |
| Colom, F | 2 |
| Capapey, J | 2 |
| Torres, I | 2 |
| Valenti, M | 2 |
| Grande, I | 2 |
| Undurraga, J | 2 |
| Drago, A | 1 |
| Giegling, I | 1 |
| Schäfer, M | 1 |
| Hartmann, AM | 1 |
| Friedl, M | 1 |
| Konte, B | 1 |
| Möller, HJ | 2 |
| De Ronchi, D | 1 |
| Stassen, HH | 1 |
| Serretti, A | 1 |
| Rujescu, D | 1 |
| Sanchez-Moreno, J | 1 |
| Gonzalez, D | 1 |
| Bienroth, M | 1 |
| Curtis, V | 1 |
| Debenham, M | 1 |
| Jones, S | 1 |
| Pitsi, D | 1 |
| George, M | 1 |
| Shi, L | 2 |
| Namjoshi, MA | 2 |
| Zhang, F | 3 |
| Gandhi, G | 1 |
| Edgell, ET | 2 |
| Breier, A | 3 |
| Haro, JM | 2 |
| Atmaca, M | 1 |
| Kuloglu, M | 1 |
| Buyukbayram, A | 1 |
| Tezcan, E | 1 |
| Grunze, H | 2 |
| Marcuse, A | 1 |
| Schärer, LO | 1 |
| Born, C | 1 |
| Walden, J | 4 |
| Koh, PO | 1 |
| Bergson, C | 1 |
| Undie, AS | 1 |
| Goldman-Rakic, PS | 1 |
| Lidow, MS | 1 |
| Gupta, S | 1 |
| Battaglia, J | 1 |
| Lindborg, SR | 2 |
| Alaka, K | 2 |
| Meehan, K | 1 |
| Wright, P | 1 |
| Akhondzadeh, S | 2 |
| Mohajari, H | 1 |
| Reza Mohammadi, M | 1 |
| Amini, H | 2 |
| Beasley, CM | 1 |
| Taylor, CC | 1 |
| GUILBERT, P | 1 |
| FERON, A | 1 |
| MONCEAUX, JP | 1 |
| LINDQVIST, R | 1 |
| ENTWISTLE, C | 1 |
| TAYLOR, RM | 1 |
| MACDONALD, IA | 1 |
| COURT, JH | 1 |
| CAMERON, IA | 1 |
| SVENDSEN, BB | 1 |
| WILLADSEN, J | 1 |
| GALINDEZ, L | 1 |
| SANTOS, MR | 1 |
| BOREL, RO | 1 |
| LEHMANN, HE | 1 |
| BAN, TA | 3 |
| KATO, G | 1 |
| GOZSY, B | 1 |
| KATO, L | 1 |
| BOHACEK, N | 1 |
| BUIS, C | 1 |
| FLOHIL, JM | 1 |
| ROTH, M | 1 |
| NAYRAC, P | 2 |
| ARNOTT, G | 2 |
| MILBLED, G | 2 |
| VOLMAT, R | 1 |
| BEAUDOUIN, JL | 1 |
| COLLIN, J | 1 |
| NICOLAS-CHARLES, PJ | 1 |
| ALLERS, G | 1 |
| FROGEL, M | 1 |
| LUNA, NE | 1 |
| Faurbye, A | 1 |
| Clausen, J | 1 |
| WEIDTMANN, W | 1 |
| Goldberg, JF | 1 |
| Gonzalez-Pinto Arrillaga, AM | 1 |
| Azorin, JM | 2 |
| Hardy-Bayle, MC | 2 |
| Lawson, WB | 1 |
| Emsley, RA | 1 |
| Baker, RW | 2 |
| Risser, RC | 2 |
| Evans, AR | 1 |
| Coffey, B | 1 |
| Onyike, CU | 1 |
| Bonner, JO | 1 |
| Lyketsos, CG | 1 |
| Treisman, GJ | 1 |
| Chagnon, YC | 1 |
| Mérette, C | 1 |
| Bouchard, RH | 1 |
| Emond, C | 1 |
| Roy, MA | 1 |
| Maziade, M | 1 |
| Jairam, R | 1 |
| Srinath, S | 1 |
| Girimaji, SC | 1 |
| Seshadri, SP | 1 |
| Sundararajan, V | 1 |
| Jainer, AK | 1 |
| Andrade, C | 1 |
| Smulevich, AB | 1 |
| Khanna, S | 1 |
| Eerdekens, M | 1 |
| Karcher, K | 1 |
| Kramer, M | 1 |
| Grossman, F | 2 |
| Laghate, VD | 1 |
| Gupta, SB | 1 |
| Storosum, JG | 1 |
| Wohlfarth, T | 1 |
| Gispen-de Wied, CC | 1 |
| Linszen, DH | 1 |
| Gersons, BP | 1 |
| van Zwieten, BJ | 1 |
| van den Brink, W | 1 |
| Witschy, JK | 1 |
| Winter, AS | 1 |
| Bourin, M | 1 |
| Marcus, R | 1 |
| Stock, E | 1 |
| Carson, W | 1 |
| Abou-Gharbia, N | 1 |
| Swanink, R | 1 |
| Iwamoto, T | 1 |
| McIntyre, RS | 1 |
| Brecher, M | 2 |
| Paulsson, B | 2 |
| Huizar, K | 1 |
| Mullen, J | 1 |
| Lim, EC | 1 |
| Wilder-Smith, EP | 1 |
| Seet, RC | 1 |
| Lewin, MR | 1 |
| Montauk, L | 1 |
| Shalit, M | 1 |
| Nobay, F | 1 |
| Cavazzoni, PA | 1 |
| Berg, PH | 1 |
| Kryzhanovskaya, LA | 1 |
| Briggs, SD | 1 |
| Roddy, TE | 1 |
| Martini, C | 1 |
| Tuscano, D | 1 |
| Trincavelli, ML | 1 |
| Cerrai, E | 1 |
| Bianchi, M | 1 |
| Ciapparelli, A | 1 |
| Alessio, L | 1 |
| Novelli, L | 1 |
| Catena, M | 1 |
| Lucacchini, A | 1 |
| Cassano, GB | 1 |
| Dell'Osso, L | 1 |
| Rendell, JM | 2 |
| Gijsman, HJ | 1 |
| Bauer, MS | 1 |
| Goodwin, GM | 1 |
| Geddes, GR | 1 |
| Tadke, RR | 1 |
| Suryavanshi, P | 1 |
| Aggarwal, P | 1 |
| Aggarwal, A | 1 |
| Suzuki, K | 1 |
| Miura, N | 1 |
| Awata, S | 1 |
| Ebina, Y | 1 |
| Takano, T | 1 |
| Honda, T | 1 |
| Shindo, T | 1 |
| Matsuoka, H | 1 |
| Juarez, R | 1 |
| Hackworth, J | 1 |
| Tohen, MF | 1 |
| El-Mallakh, RS | 1 |
| Decker, S | 1 |
| Morris, M | 1 |
| Li, XP | 1 |
| Huff, MO | 1 |
| El-Masri, MA | 1 |
| Levy, RS | 1 |
| Cipriani, A | 1 |
| Geddes, JR | 1 |
| Papazisis, G | 1 |
| Kouvelas, D | 1 |
| Mastrogianni, A | 1 |
| Karastergiou, A | 1 |
| Nasrallah, HA | 1 |
| Milajerdi, MR | 1 |
| Tehrani-Doost, M | 1 |
| Roberts-Thomson, KC | 1 |
| Teo, KS | 1 |
| Young, GD | 1 |
| Moreno, RA | 1 |
| Hanna, MM | 1 |
| Tavares, SM | 1 |
| Wang, YP | 1 |
| Gómez-Herreros, R | 1 |
| Gotor Sánchez-Luengo, F | 1 |
| del Valle-Villagrán, J | 1 |
| Fernández-López, I | 1 |
| Tamayo, JM | 1 |
| Mazzotti, G | 1 |
| Gattaz, WF | 1 |
| Zapata, R | 1 |
| Castillo, JJ | 1 |
| Fahrer, RD | 1 |
| González-Pinto, AM | 1 |
| Brown, E | 1 |
| Brunner, E | 1 |
| Rovner, J | 1 |
| Bonett-Perrin, E | 1 |
| Brahm, NC | 1 |
| Gutierres, SL | 1 |
| Carnahan, RM | 1 |
| Kim, B | 1 |
| Kim, SJ | 1 |
| Son, JI | 1 |
| Joo, YH | 1 |
| Currier, GW | 1 |
| Citrome, LL | 1 |
| Zimbroff, DL | 1 |
| Oren, D | 1 |
| Manos, G | 1 |
| Pikalov, AA | 1 |
| Crandall, DT | 1 |
| Amar, S | 1 |
| Shaltiel, G | 1 |
| Mann, L | 1 |
| Shamir, A | 1 |
| Bersudsky, Y | 2 |
| Belmaker, RH | 7 |
| Agam, G | 3 |
| Lorenz, RA | 1 |
| Weinstein, B | 1 |
| Hassan, M | 1 |
| Madhavan, SS | 1 |
| Kalsekar, ID | 1 |
| Makela, EH | 1 |
| Rajagopalan, K | 1 |
| Islam, S | 1 |
| Kavookjian, J | 1 |
| Miller, LA | 1 |
| Gao, K | 1 |
| Ganocy, SJ | 1 |
| Gajwani, P | 1 |
| Muzina, DJ | 1 |
| Kemp, DE | 1 |
| Calabrese, JR | 1 |
| Berk, M | 1 |
| Ng, F | 1 |
| Wang, WV | 1 |
| Lubman, DI | 1 |
| Dodd, S | 1 |
| Nurnberg, HG | 1 |
| Spring, G | 1 |
| Frankel, M | 1 |
| Goekoop, JG | 1 |
| Carbaat, PA | 1 |
| Tyrer, SP | 1 |
| Planche, R | 1 |
| Kelwala, S | 1 |
| Berney, SA | 1 |
| Wilson, WH | 1 |
| Baldessarini, RJ | 1 |
| Katz, B | 1 |
| Cotton, P | 1 |
| Kanter, GL | 1 |
| Yerevanian, BI | 2 |
| Ciccone, JR | 1 |
| arap Mengech, HN | 1 |
| Wazome, EG | 1 |
| Waters, BG | 1 |
| Lapierre, YD | 1 |
| Keegan, DL | 1 |
| Richardson, JS | 1 |
| Kirby, AR | 1 |
| Klein, E | 1 |
| Bental, E | 1 |
| Lerer, B | 1 |
| DePaulo, JR | 1 |
| Chouinard, G | 4 |
| Young, SN | 1 |
| Annable, L | 2 |
| Reches, A | 1 |
| Hassan, MN | 1 |
| Jackson, V | 1 |
| Fahn, S | 1 |
| Sandyk, R | 1 |
| Hurwitz, MD | 1 |
| Settle, EC | 1 |
| Ayd, FJ | 2 |
| Schaffer, CB | 1 |
| Batra, K | 1 |
| Garvey, MJ | 1 |
| Mungas, DM | 1 |
| Schaffer, LC | 1 |
| Garfinkel, PE | 1 |
| Stancer, HC | 1 |
| Persad, E | 1 |
| Zubenko, GS | 2 |
| Barreira, P | 1 |
| Lipinski, JF | 1 |
| Balant-Gorgia, AE | 1 |
| Eisele, R | 1 |
| Balant, L | 1 |
| Garrone, G | 1 |
| Mann, SC | 1 |
| Greenstein, RA | 1 |
| Eilers, R | 1 |
| Werstiuk, ES | 1 |
| Grof, P | 1 |
| Rotstein, E | 1 |
| Werner, L | 1 |
| Fernando, J | 1 |
| Krishna Raju, R | 1 |
| Jones, GG | 1 |
| Stanley, RO | 1 |
| Altesman, RI | 1 |
| Cassidy, JW | 1 |
| Barreira, PJ | 1 |
| McBurney, A | 1 |
| George, S | 1 |
| Menes, C | 1 |
| Burra, P | 1 |
| Hoaken, PC | 1 |
| Bond, WS | 1 |
| Carvalho, M | 1 |
| Foulks, EF | 1 |
| Parent, M | 3 |
| Toussaint, C | 3 |
| Cookson, JC | 2 |
| Moult, PJ | 1 |
| Wiles, D | 1 |
| Besser, GM | 2 |
| Nurnberger, JI | 1 |
| Gershon, ES | 1 |
| Simmons, S | 1 |
| Ebert, M | 1 |
| Kessler, LR | 1 |
| Dibble, ED | 1 |
| Jimerson, SS | 1 |
| Brown, GM | 1 |
| Gold, P | 1 |
| Jimerson, DC | 1 |
| Guroff, JJ | 1 |
| Storch, FI | 1 |
| Schreier, HA | 1 |
| Rudorfer, MV | 1 |
| Raichman, JA | 1 |
| Glazer, WM | 1 |
| Sheard, MH | 1 |
| Shur, E | 1 |
| Checkley, S | 1 |
| Weiner, WJ | 1 |
| Werner, TR | 1 |
| Fishbain, DA | 1 |
| Spehr, W | 1 |
| Andresen, B | 1 |
| Pascher, W | 1 |
| Shopsin, B | 3 |
| Kline, N | 1 |
| Coffey, CE | 1 |
| Ross, DR | 1 |
| Goldney, RD | 2 |
| Temme, PB | 1 |
| Bech, P | 2 |
| Shapiro, RW | 1 |
| Sihm, F | 1 |
| Nielsen, BM | 1 |
| Sørensen, B | 1 |
| Rafaelsen, OJ | 1 |
| Small, JG | 3 |
| Klapper, MH | 3 |
| Marhenke, JD | 2 |
| Milstein, V | 3 |
| Woodham, GC | 1 |
| Kellams, JJ | 1 |
| Damodaran, SS | 2 |
| Jayalekshmi, KT | 1 |
| Khanna, R | 2 |
| Pearlson, GD | 1 |
| Wong, DF | 1 |
| Tune, LE | 1 |
| Ross, CA | 1 |
| Chase, GA | 1 |
| Links, JM | 1 |
| Dannals, RF | 1 |
| Wilson, AA | 1 |
| Ravert, HT | 1 |
| Wagner, HN | 1 |
| Oesterheld, JR | 1 |
| Shader, RI | 1 |
| Nowlin-Finch, NL | 1 |
| Altshuler, LL | 1 |
| Szuba, MP | 1 |
| Mintz, J | 1 |
| Raja, M | 1 |
| Altavista, MC | 1 |
| Cavallari, S | 1 |
| Lubich, L | 1 |
| Rifkin, A | 2 |
| Doddi, S | 2 |
| Karajgi, B | 2 |
| Borenstein, M | 1 |
| Munne, R | 1 |
| Benazzi, F | 1 |
| Mazzoli, M | 1 |
| Chakraborty, SP | 1 |
| Greedharry, D | 1 |
| Bowen, R | 1 |
| Lang, AE | 1 |
| Wright, JB | 1 |
| Turnier, L | 1 |
| Holobow, N | 1 |
| Szkrumelak, N | 1 |
| Spivak, B | 4 |
| Radwan, M | 3 |
| Brandon, J | 3 |
| Baruch, Y | 1 |
| Stawski, M | 1 |
| Tyano, S | 3 |
| Weizman, A | 5 |
| Remington, G | 1 |
| Pollock, B | 2 |
| Voineskos, G | 2 |
| Reed, K | 2 |
| Coulter, K | 2 |
| Finnerty, M | 1 |
| Levin, Z | 1 |
| Miller, LJ | 1 |
| McElroy, SL | 1 |
| Keck, PE | 3 |
| Stanton, SP | 1 |
| Tugrul, KC | 1 |
| Bennett, JA | 1 |
| Strakowski, SM | 2 |
| Mani, J | 1 |
| Tandel, SV | 1 |
| Shah, PU | 1 |
| Karnad, DR | 1 |
| Byrd, RP | 1 |
| Lukeman, RW | 1 |
| Mathai, M | 1 |
| Mathew, MK | 1 |
| Chang, WH | 2 |
| Jann, MW | 1 |
| Chiang, TS | 1 |
| Lin, HN | 1 |
| Hu, WH | 1 |
| Chien, CP | 1 |
| Liu, CY | 1 |
| Wang, SJ | 1 |
| Fuh, JL | 1 |
| Yang, YY | 1 |
| Liu, HC | 1 |
| Maes, M | 1 |
| De Meester, I | 1 |
| Scharpe, S | 1 |
| Desnyder, R | 1 |
| Ranjan, R | 1 |
| Meltzer, HY | 1 |
| Small, IF | 1 |
| Roxanas, MG | 1 |
| Corbett, AJ | 1 |
| Reid, WG | 1 |
| Galynker, II | 1 |
| Nazarian, D | 1 |
| Strite, D | 1 |
| Valentine, AD | 1 |
| Meyers, CA | 1 |
| Schlösser, R | 1 |
| Schlegel, S | 1 |
| Hiemke, C | 1 |
| Nickel, O | 1 |
| Bockisch, A | 1 |
| Rao, ML | 1 |
| Hahn, K | 1 |
| Irwin, R | 1 |
| Ellis, PM | 1 |
| Delahunt, J | 1 |
| Zarate, CA | 1 |
| Narendran, R | 1 |
| Greaney, JJ | 1 |
| Berman, A | 1 |
| Pike, S | 1 |
| Madrid, A | 1 |
| Mazure, CM | 3 |
| Bowers, MB | 3 |
| Iancu, I | 1 |
| Mester, R | 1 |
| Malloy, FW | 1 |
| Golay, SJ | 1 |
| Medlock, CE | 1 |
| Abouesh, A | 1 |
| Hobbs, WR | 1 |
| Normann, C | 2 |
| Brandt, C | 1 |
| Berger, M | 1 |
| Gannon, MA | 1 |
| O'Sullivan, P | 1 |
| Karege, F | 1 |
| Golaz, J | 1 |
| Schwald, M | 1 |
| Malafosse, A | 1 |
| Kline, MD | 1 |
| Jaggers, ED | 1 |
| Chou, JC | 3 |
| Czobor, P | 3 |
| Charles, O | 2 |
| Tuma, I | 3 |
| Winsberg, B | 1 |
| Allen, MH | 1 |
| Trujillo, M | 2 |
| Volavka, J | 2 |
| Langosch, J | 1 |
| Schaerer, LO | 1 |
| Bozikas, V | 1 |
| Vartzopoulos, D | 1 |
| Phocas, C | 1 |
| Karavatos, A | 1 |
| Kaprinis, G | 1 |
| Mishory, A | 1 |
| Yaroslavsky, Y | 1 |
| Heiden, A | 1 |
| Frey, R | 1 |
| Presslich, O | 1 |
| Blasbichler, T | 1 |
| Smetana, R | 1 |
| Kasper, S | 1 |
| Müller-Oerlinghausen, B | 1 |
| Retzow, A | 1 |
| Henn, FA | 1 |
| Giedke, H | 1 |
| Bebe, R | 1 |
| Cooper, TB | 2 |
| Lane, HY | 1 |
| Stone, DL | 1 |
| Shapiro, J | 1 |
| Biegon, A | 1 |
| Seker, A | 1 |
| Baastrup, PC | 2 |
| de Bleeker, E | 1 |
| Ropert, R | 1 |
| Janicak, PG | 1 |
| Davis, JM | 2 |
| Kasckow, JW | 1 |
| Tugrul, K | 1 |
| Dowd, SM | 1 |
| Strong, J | 1 |
| Sharma, RP | 1 |
| Dacpano, G | 1 |
| Richardson, N | 1 |
| Hua, LV | 1 |
| Green, M | 1 |
| Wong, A | 1 |
| Warsh, JJ | 1 |
| Li, PP | 1 |
| Kafantaris, V | 1 |
| Dicker, R | 1 |
| Coletti, DJ | 1 |
| Feldman, PD | 1 |
| Tran, PV | 1 |
| Yatham, LN | 1 |
| Potkin, SG | 1 |
| Thyrum, PT | 1 |
| Alva, G | 1 |
| Bera, R | 1 |
| Yeh, C | 1 |
| Arvanitis, LA | 1 |
| Ranjan, S | 1 |
| Jagadheesan, K | 1 |
| Nizamie, SH | 1 |
| Sachs, GS | 1 |
| Ghaemi, SN | 1 |
| Okamoto, A | 1 |
| Bowden, CL | 1 |
| Cesková, E | 1 |
| Náhunek, K | 1 |
| Svestka, J | 1 |
| Rodová, A | 1 |
| Corsini, GU | 1 |
| Del Zompo, M | 1 |
| Manconi, S | 1 |
| Cianchetti, C | 1 |
| Mangoni, A | 1 |
| Gessa, GL | 1 |
| White, JH | 1 |
| O'Shanick, G | 1 |
| Pühringer, W | 1 |
| Kocher, R | 1 |
| Gastpar, M | 1 |
| Goodwin, FK | 1 |
| Zis, AP | 1 |
| Charney, DS | 1 |
| Kales, A | 1 |
| Soldatos, CR | 1 |
| Nelson, JC | 3 |
| Loudon, JB | 1 |
| Waring, H | 1 |
| Mehta, D | 1 |
| Mehta, S | 1 |
| Petit, J | 1 |
| Shriner, W | 1 |
| Kirkegaard, C | 1 |
| Bjørum, N | 1 |
| Cohn, D | 1 |
| Lauridsen, UB | 1 |
| Bunney, WE | 1 |
| Pert, A | 1 |
| Rosenblatt, J | 1 |
| Pert, CB | 1 |
| Gallaper, D | 1 |
| Ehle, G | 1 |
| Uebelhack, R | 1 |
| van Leeuwen, AM | 1 |
| Molders, J | 1 |
| Sterkmans, P | 1 |
| Mielants, P | 1 |
| Martens, C | 1 |
| Hovent, AM | 1 |
| Desseilles, MF | 1 |
| Koch, H | 1 |
| Devroye, A | 1 |
| Ballenger, JC | 1 |
| Post, RM | 1 |
| Donlon, PT | 1 |
| Hopkin, J | 1 |
| Tupin, JP | 1 |
| Biederman, J | 1 |
| Lerner, Y | 2 |
| Lwow, E | 1 |
| Levitin, A | 1 |
| Dudley, DL | 1 |
| Rowlett, DB | 1 |
| Loebel, PJ | 1 |
| Economou, SG | 1 |
| Stefanis, CN | 1 |
| Lenz, G | 2 |
| König, P | 2 |
| Küfferle, B | 2 |
| Pecknold, JC | 1 |
| Carpenter, WT | 1 |
| Juhl, RP | 1 |
| Tsuang, MT | 1 |
| Perry, PJ | 1 |
| Bódog, G | 1 |
| Brion, S | 1 |
| Chevalier, JF | 1 |
| Guerin, R | 1 |
| Ginestet, D | 1 |
| Hollnagel, P | 1 |
| Sorensen, R | 1 |
| Schou, M | 1 |
| Gershon, S | 2 |
| Thompson, H | 1 |
| Collins, P | 1 |
| Warneke, L | 1 |
| Hemsley, DR | 1 |
| Philips, HC | 1 |
| Hermesh, H | 1 |
| Aizenberg, D | 1 |
| Lapidot, M | 1 |
| Mayor, C | 1 |
| Munitz, H | 1 |
| De Beaurepaire, R | 1 |
| Steadman, P | 1 |
| Egorov, AY | 1 |
| Nikolaenko, NN | 1 |
| Lenox, RH | 1 |
| Newhouse, PA | 1 |
| Creelman, WL | 1 |
| Whitaker, TM | 1 |
| Warkentin, S | 1 |
| Nilsson, A | 1 |
| Karlson, S | 1 |
| Risberg, J | 1 |
| Franze'n, G | 1 |
| Gustafson, L | 1 |
| Jatlow, PI | 2 |
| Roffe, C | 1 |
| Patel, V | 1 |
| Abbott, RJ | 1 |
| Czapla, K | 1 |
| Besson, JA | 1 |
| Holland, J | 1 |
| Wheeldon, T | 1 |
| Ebmeier, KP | 1 |
| Molcho, A | 1 |
| Ohring, R | 1 |
| Tondo, L | 1 |
| Rudas, N | 1 |
| Bartur, P | 1 |
| Rosenberg, DR | 1 |
| Remington, GJ | 1 |
| Roca, RP | 1 |
| Blackman, MR | 1 |
| Ackerley, MB | 1 |
| Harman, SM | 1 |
| Gregerman, RI | 1 |
| Moscovich, DG | 1 |
| Livne, A | 1 |
| Bennett, DA | 1 |
| Kulkarni, J | 1 |
| Keks, NA | 1 |
| Stuart, G | 1 |
| Mackie, B | 1 |
| Minas, IH | 1 |
| Singh, BS | 1 |
| Copolov, DL | 1 |
| Ghadirian, AM | 3 |
| Kusalic, M | 2 |
| Cooper, T | 1 |
| Saran, A | 1 |
| Addy, O | 1 |
| Foliart, RH | 1 |
| Schubert, DS | 1 |
| Halaris, A | 1 |
| Kissling, W | 1 |
| Riehl, T | 1 |
| Bäuml, J | 1 |
| Binz, U | 1 |
| Wendt, G | 1 |
| Nair, NP | 2 |
| Schwartz, G | 2 |
| Ward, MR | 1 |
| Corbett, JA | 1 |
| Tate, JL | 1 |
| Van Bellinghen, M | 1 |
| Peuskens, J | 1 |
| Applemans, A | 1 |
| Brown, D | 1 |
| Silverstone, T | 2 |
| Cookson, J | 1 |
| Nasser, J | 1 |
| Thomas, B | 1 |
| Collins, C | 1 |
| Oakley-Browne, M | 1 |
| Wagemaker, H | 1 |
| Lippmann, S | 1 |
| Cade, JR | 1 |
| Lowe, MR | 2 |
| Spence, ND | 1 |
| Miller, F | 1 |
| Menninger, J | 1 |
| Bulens, C | 1 |
| Meerwaldt, JD | 1 |
| van der Wildt, GJ | 1 |
| Keemink, CJ | 1 |
| Williams, DP | 1 |
| Troost, BT | 1 |
| Rogers, J | 1 |
| Goldschmidt, TJ | 1 |
| Burch, EA | 1 |
| Gutnisky, G | 1 |
| Cohen, LS | 1 |
| Rosenbaum, JF | 1 |
| Heller, VL | 1 |
| Brayley, J | 1 |
| Yellowlees, P | 1 |
| Loew, MR | 1 |
| Batchelor, DH | 1 |
| Perera, HV | 1 |
| Bourgeois, M | 1 |
| Degeilh, B | 1 |
| Van Gent, EM | 1 |
| Nabarro, G | 1 |
| Brewerton, TD | 1 |
| Snyder, JW | 1 |
| Poe, RO | 1 |
| Stubbins, JF | 1 |
| Garrettson, LK | 1 |
| Gonçalves, N | 1 |
| Stoll, KD | 1 |
| Khan, A | 1 |
| Jaffe, JH | 1 |
| Nelson, WH | 1 |
| Morrison, B | 1 |
| Sobel, SV | 1 |
| Fainman, C | 1 |
| Kripke, DF | 1 |
| Fisman, S | 1 |
| Max, P | 1 |
| Woodside, DB | 1 |
| Fast, DK | 1 |
| Jones, BD | 1 |
| Erickson, M | 1 |
| Baer, L | 1 |
| Minichiello, WE | 1 |
| Jenike, MA | 1 |
| Campbell, WG | 1 |
| Raskind, MA | 1 |
| Gordon, T | 1 |
| Shaw, CM | 1 |
| Valenstein, M | 1 |
| Maltbie, A | 1 |
| Kaplan, P | 1 |
| Hodgman, CH | 1 |
| Aronson, TA | 1 |
| Williams, S | 1 |
| de Groot, MH | 1 |
| Avrutskii, GIa | 1 |
| Gurovich, IIa | 2 |
| Prokhorova, IS | 1 |
| Tirkel'taub, IuA | 1 |
| Romanov, IuD | 1 |
| Blackwell, B | 1 |
| Shepherd, M | 1 |
| Man, PL | 1 |
| Dhasmana, KM | 1 |
| Dixit, KS | 1 |
| Jaju, BP | 1 |
| Gupta, ML | 1 |
| Marhold, J | 1 |
| Zimanová, J | 1 |
| Lachman, M | 1 |
| Král, J | 1 |
| Vojtĕchovský, M | 1 |
| Gill, J | 1 |
| de L Horne, DJ | 1 |
| Sedvall, G | 1 |
| Fyrö, B | 1 |
| Nybäck, H | 1 |
| Wiesel, FA | 1 |
| Wode-Helgodt, B | 1 |
| Cohen, WJ | 1 |
| Cohen, NH | 1 |
| McMurdo, R | 1 |
| Jeffries, JJ | 1 |
| Lefebvre, A | 1 |
| James, N | 1 |
| Gerle, B | 2 |
| Rees, WL | 1 |
| Janssen, PA | 1 |
| Simpson, GM | 1 |
| Dunlop, E | 1 |
| Kammerer, M | 1 |
| Wartel, R | 1 |
| Gurfein, L | 1 |
| Weil, J | 1 |
| Wysoki, V | 1 |
| Gelb, F | 1 |
| Bechthold, HG | 1 |
| Schottky, A | 1 |
| Morgan, HG | 1 |
| Demers, RG | 1 |
| Fleĭs, EP | 1 |
| de Barros-Ferreira, M | 1 |
| Mattos, E | 1 |
| Inose, T | 1 |
| Hirata, I | 1 |
| Kawajiwara, A | 1 |
| Iwata, T | 1 |
| Tano, T | 1 |
| Rapp, MS | 1 |
| Nuller, IuL | 1 |
| Rabinovich, MM | 1 |
| Vovina, EN | 1 |
| Vovin, RIa | 1 |
| Meyer, HH | 1 |
| Flügel, KA | 1 |
| Pfeiffer, WM | 1 |
| Blinder, MG | 1 |
| Furlong, FW | 1 |
| Hendrie, H | 1 |
| Luby, ED | 1 |
| Greger, J | 1 |
| Glitschka, A | 1 |
| Müller, K | 1 |
| Hezar-Khani, F | 1 |
| Vogelberg, K | 1 |
| Mori, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Observational Study of Anti-Psychotic Medication for the Treatment of Agitation in the Emergency Department[NCT02877108] | 100 participants (Anticipated) | Observational | 2016-04-30 | Recruiting | |||
| A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder[NCT00097266] | Phase 3 | 615 participants | Interventional | 2004-12-31 | Completed | ||
| Comparative Efficacy and Acceptability of Lithium, Valproate, Oxcarbazepine, Quetiapine, Olanzapine, and Ziprasidone in Bipolar I Disorder, Manic or Mixed Phase[NCT01893229] | Phase 4 | 120 participants (Anticipated) | Interventional | 2013-09-30 | Recruiting | ||
| Placebo- and Haloperidol-Controlled Double-Blind Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder[NCT00129220] | Phase 3 | 224 participants (Actual) | Interventional | 2005-07-31 | Completed | ||
| The Efficacy And Safety Of Flexible Dose Ranges Of Risperidone Versus Placebo Or Haloperidol In The Treatment Of Manic Episodes Associated With Bipolar I Disorder.[NCT00253162] | Phase 3 | 439 participants (Actual) | Interventional | 2001-03-31 | Completed | ||
| Aripiprazole for Pre-Existing Neuroleptic-Induced Tardive Dyskinesia: a Prospective 26-Week Observational Study[NCT00837707] | Phase 4 | 25 participants (Anticipated) | Interventional | 2008-06-30 | Recruiting | ||
| Aripiprazole, Abilify Maintena Collaborative Clinical Protocol[NCT02717130] | 9 participants (Actual) | Interventional | 2016-06-08 | Terminated (stopped due to The study was terminated due to lack of enrollment.) | |||
| The Safety And Efficacy Of Risperdal� (Risperidone) Versus Placebo Versus Haloperidol As Add-On Therapy To Mood Stabilizers In The Treatment Of The Manic Phase Of Bipolar Disorder[NCT00253149] | Phase 3 | 158 participants (Actual) | Interventional | Completed | |||
| Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia[NCT00156715] | Phase 4 | 23 participants (Actual) | Interventional | 2004-03-31 | Completed | ||
| Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)[NCT00130923] | Phase 4 | 95 participants (Actual) | Interventional | 2005-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60. (NCT00129220)
Timeframe: Baseline, 3 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| Olanzapine | -12.6 |
| Haloperidol | -14.3 |
| Placebo | -6.8 |
A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of overall mood symptoms on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients). (NCT00129220)
Timeframe: Baseline, 6 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| Olanzapine | -1.6 |
| Haloperidol | -1.3 |
| Placebo | -0.9 |
The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60. (NCT00129220)
Timeframe: Baseline, 6 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| Olanzapine | -16.0 |
| Haloperidol | -14.7 |
| Placebo | -10.1 |
Remission of bipolar disorder was defined as completing the 6-week period with meeting the criteria for Young Mania Rating Scale (YMRS) total score of 12 or less and 17-Item Hamilton Depression Rating Scale (HAMD-17) total scores of 7 or less at Week 6. YMRS is an 11-item scale measuring severity of manic episodes; total score ranges = 0 (normal) to 60 (severe). The 17-item HAMD measures depression severity; total score ranges = 0 (normal) to 52 (severe). Remission Rate (percent) = number of patients meeting remission criteria divided by number of patients in treatment arm, multiplied by 100. (NCT00129220)
Timeframe: 6 weeks
| Intervention | percentage of participants (Number) |
|---|---|
| Olanzapine | 44.2 |
| Haloperidol | 20.0 |
A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients). (NCT00129220)
Timeframe: Baseline, 3 weeks, 6 weeks
| Intervention | units on a scale (Mean) | |
|---|---|---|
| 3-Week Change | 6-Week Change | |
| Haloperidol | -1.7 | -1.9 |
| Olanzapine | -1.2 | -1.7 |
| Placebo | -0.6 | -1.0 |
Assesses positive symptoms associated with schizophrenia. 7 items make up the Positive scale (ex. delusions, conceptual disorganization, and hallucinatory behavior). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Positive Subscale scores range from 7 to 49. For this study, the score was converted to 0 to 6 for each item range; hence, the total positive subscale score ranges from 0 to 42. (NCT00129220)
Timeframe: Baseline, 3 weeks, 6 weeks
| Intervention | units on a scale (Mean) | |
|---|---|---|
| 3-Week Change | 6-Week Change | |
| Haloperidol | -1.8 | -1.6 |
| Olanzapine | -1.8 | -2.2 |
| Placebo | -0.0 | -0.3 |
Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS) is a scale used to evaluate the severity of drug induced extra-pyramidal symptoms occurring during antipsychotic drug treatment. Scale consists of 8 individual symptom scales with scores ranging from 0 (none/normal) to 4 (severe). The total score is the sum of the 8 item scores, for a total range of 0 (normal) to 32 (severe). (NCT00129220)
Timeframe: Baseline to 6 weeks
| Intervention | units on a scale (Mean) | |
|---|---|---|
| Baseline | Maximum Change from Baseline | |
| Haloperidol | 0.50 | 2.70 |
| Olanzapine | 0.20 | 0.70 |
| Placebo | 0.30 | 0.09 |
Switch to symptomatic depression was defined as HAMD-17 total score ≥13 at any time in the participants with HAMD-17 total scores ≤7 at baseline. The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe). (NCT00129220)
Timeframe: 3 weeks, 6 weeks
| Intervention | percentage of participants (Number) | |
|---|---|---|
| 3-Week Symptomatic Depression Rate | 6-Week Symptomatic Depression Rate | |
| Haloperidol | 16.7 | 16.7 |
| Olanzapine | 2.4 | 2.4 |
| Placebo | 1.3 | 2.7 |
Switch to syndromic depression was operationally defined by meeting both of the following criteria: At baseline, the symptoms did not meet the criteria for a mixed episode based on the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR). The critiera were met for a Major Depressive Episode (MDE), at any point after randomization, based on DSM-IV-TR. Rather than the 2-week period required for an MDE in the DSM-IV-TR, the patient had to meet the criteria of an MDE for at least 7 consecutive days (during Weeks 1 through 6). (NCT00129220)
Timeframe: 3 weeks, 6 weeks
| Intervention | percentage of participants (Number) | |
|---|---|---|
| 3-Week Syndromic Depression Rate | 6-Week Syndromic Depression Rate | |
| Haloperidol | 5.3 | 5.3 |
| Olanzapine | 0.0 | 1.1 |
| Placebo | 0.0 | 0.0 |
Participants who had a YMRS total score of 12 or less were considered to be in remission of manic symptoms. YMRS is an 11-item scale that measures severity of manic episodes; total score ranges from 0 (normal) to 60 (severe). Remission Rate (percent) = number of patients meeting remission criteria divided by number of patients in treatment arm, multiplied by 100. (NCT00129220)
Timeframe: 3 weeks, 6 weeks
| Intervention | percentage of participants (Number) | |
|---|---|---|
| 3-Week Remission Rate | 6-Week Remission Rate | |
| Haloperidol | 65.0 | 60.0 |
| Olanzapine | 47.1 | 63.5 |
| Placebo | 41.2 | 52.6 |
Participants who had 50 percent or more decrease from the baseline in YMRS total scores were defined as a responder. The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60. Response Rate (percent) = number of patients meeting response criterion for manic symptom divided by number of patients in treatment arm, multiplied by 100. (NCT00129220)
Timeframe: Baseline, 3 weeks, 6 weeks
| Intervention | percentage of participants (Number) | |
|---|---|---|
| 3 Week Response Rate | 6 Week Response Rate | |
| Haloperidol | 65.0 | 65.0 |
| Olanzapine | 51.0 | 67.3 |
| Placebo | 44.3 | 55.7 |
The main outcome measure of clinical symptoms was the Positive and Negative Symptoms Scale. This is a 30 item scale for assessing patients diagnosed with schizophrenia. Each item is rated on a 1 (absent) to 7 (extreme) scale. The minimum total score is 30 and the maximum is 210. (NCT00156715)
Timeframe: 12 Weeks
| Intervention | Units on a scale (Mean) |
|---|---|
| QUET | 65.5 |
Timeline Follow-back (TLFB) procedure was used at screening and baseline to establish current substance use, and it was also used weekly during the course of the study to assess continued alcohol and other substance use. TLFB cosisted of using a calendar and sasking participants to report alcohol and other drug use since last visit. At the screening visit, the TLFB was done for the four weeks prior to the visit. (NCT00156715)
Timeframe: 12 Weeks
| Intervention | Drinking Days per Week (Mean) |
|---|---|
| QUET | 2.7 |
Frequency of drinking days is obtained each week retrospectively as the number of drinking days during the prior week (assessed using the Timeline Followback). Mixed models are used to obtain estimates of efficacy from the partial data provided by each subject while adherent to assigned treatment (under the 'missing at random' assumption). The 'explanatory' estimands (target of the mixed model estimation) are defined in terms of population quantities that would have occurred had all subjects remained on assigned treatment throughout the study. The point estimate for each arm is reported under Number. (NCT00130923)
Timeframe: 6 months
| Intervention | drinking days per week (Number) |
|---|---|
| Risperidone Long Acting Injectable (LAI) | 2.84 |
| Oral Risperidone Aka Risperdal | 3.46 |
A rater assesses social, occupational and psychological functioning on a hypothetical continuum of mental health - illness (using Global Assessment of Functioning); scores range from 100 to 1, where higher values represent a better outcome. Mixed models are used to obtain estimates of efficacy from the partial data provided by each subject while adherent to assigned treatment (under the 'missing at random' assumption). The 'explanatory' estimands (target of the mixed model estimation) are defined in terms of population quantities that would have occurred had all subjects remained on assigned treatment throughout the study. The point estimate for each arm is reported under Number. (NCT00130923)
Timeframe: 6 months
| Intervention | ordinal severity of impairment (Number) |
|---|---|
| Risperidone Long Acting Injectable (LAI) | 50.8 |
| Oral Risperidone Aka Risperdal | 49.9 |
A rater assesses positive and negative symptoms of schizophrenia using a 30-item scale (Positive and Negative Symptom Score) Scores range from 30 to 210, where higher values represent a worse outcome. Mixed models are used to obtain estimates of efficacy from the partial data provided by each subject while adherent to assigned treatment (under the 'missing at random' assumption). The 'explanatory' estimands (target of the mixed model estimation) are defined in terms of population quantities that would have occurred had all subjects remained on assigned treatment throughout the study. The point estimate for each arm is reported under Number. (NCT00130923)
Timeframe: 6 months
| Intervention | ordinal severity of symptoms (Number) |
|---|---|
| Risperidone Long Acting Injectable (LAI) | 78.2 |
| Oral Risperidone Aka Risperdal | 75.5 |
A rater assesses the severity of illness and global impression using a scale from 1 to 7 (Clinical Global Impression), where higher values represent a worse outcome. Mixed models are used to obtain estimates of efficacy from the partial data provided by each subject while adherent to assigned treatment (under the 'missing at random' assumption). The 'explanatory' estimands (target of the mixed model estimation) are defined in terms of population quantities that would have occurred had all subjects remained on assigned treatment throughout the study. The point estimate for each arm is reported under Number. (NCT00130923)
Timeframe: 6 months
| Intervention | ordinal unit of severity (Number) |
|---|---|
| Risperidone Long Acting Injectable (LAI) | 4.02 |
| Oral Risperidone Aka Risperal | 3.96 |
Frequency of heavy drinking days is obtained each week retrospectively as the number of heavy drinking days during the prior week (assessed by the Timeline Followback Scale). A heavy drinking day is defined as 4 or more drinks per day for a female and 5 or more drinks per day for a male. Mixed models are used to obtain estimates of efficacy from the partial data provided by each subject while adherent to assigned treatment (under the 'missing at random' assumption). The 'explanatory' estimands (target of the mixed model estimation) are defined in terms of population quantities that would have occurred had all subjects remained on assigned treatment throughout the study. The point estimate for each arm is reported under Number. (NCT00130923)
Timeframe: 6 months
| Intervention | heavy drinking days per week (Number) |
|---|---|
| Risperidone Long Acting Injectable (LAI) | -.11 |
| Oral Risperidone Aka Risperal | .68 |
Number of participants with medication adherence (defined as taking medication at least 75% of the days in the treatment period). (NCT00130923)
Timeframe: 6 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Risperidone Long Acting Injectable (LAI) | 43 |
| Oral Risperidone Aka Risperdal | 28 |
23 reviews available for haloperidol and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; | 2022 |
Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Haloperidol; Humans; Mania; Olanzapine; Quetia | 2023 |
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Depressio | 2021 |
Aripiprazole alone or in combination for acute mania.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Dr | 2013 |
Capgras delusion with violent behavior in Alzheimer dementia: case analysis with literature review.
Topics: Aged; Aggression; Alzheimer Disease; Amitriptyline; Anticonvulsants; Antidepressive Agents, Tricycli | 2014 |
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Haloperi | 2010 |
Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials.
Topics: Adolescent; Adult; Age Factors; Akathisia, Drug-Induced; Anti-Obesity Agents; Antimanic Agents; Anti | 2010 |
CNS drug development. Part I: The early period of CNS drugs.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Central | 2010 |
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disord | 2013 |
Safety in treating bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Diabetes Melli | 2003 |
The treatment of mixed states and the risk of switching to depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Electroco | 2005 |
Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Brief Psychi | 2006 |
Risperidone alone or in combination for acute mania.
Topics: Antipsychotic Agents; Bipolar Disorder; Chemotherapy, Adjuvant; Haloperidol; Humans; Lithium; Random | 2006 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; D | 2006 |
Quetiapine for acute mania in bipolar disorder.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Drug In | 2007 |
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Bl | 2008 |
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Double-Blind Method; Fe | 2008 |
Lithium.
Topics: Aggression; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, C | 1984 |
Withdrawal akathisia: case reports and a proposed classification of chronic akathisia.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Bipolar Disorder; Dose-Response Relationship, Drug; Drug | 1994 |
The role of novel antipsychotics in bipolar disorders.
Topics: Acute Disease; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Lithium; Ol | 2002 |
Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol.
Topics: Acute Disease; Administration, Oral; Basal Ganglia Diseases; Bipolar Disorder; Clinical Trials as To | 1979 |
Haloperidol in the therapy of severe behavior disorders.
Topics: Benperidol; Bipolar Disorder; Child Behavior; Dementia; Droperidol; Haloperidol; Humans; Neurocognit | 1976 |
Clonazepam in acute and maintenance treatment of bipolar affective disorder.
Topics: Acute Disease; Adult; Bipolar Disorder; Clinical Trials as Topic; Clonazepam; Double-Blind Method; D | 1987 |
68 trials available for haloperidol and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Have antipsychotics a different speed of action in the acute treatment of mania? A single-blind comparative study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzocycloheptenes; Female; Halope | 2017 |
Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Female; Haloperidol; Humans; Ind | 2010 |
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Do | 2009 |
The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Dru | 2008 |
Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Haloperidol | 2010 |
A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania.
Topics: Adult; Aged; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Dibenzothiepins; Drug Adminis | 2010 |
Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Dru | 2011 |
Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; H | 2012 |
Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
Topics: Acute Disease; Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Body Wei | 2012 |
Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Haloperidol; Humans; Random | 2013 |
Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; | 2002 |
Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; An | 2002 |
Calming versus sedative effects of intramuscular olanzapine in agitated patients.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dementia; Doubl | 2003 |
Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
Topics: Acute Disease; Adult; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Haloperidol; | 2003 |
Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dementia; Dose-Response Relationship, Drug; | 2003 |
A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dose-Response Relatio | 2003 |
A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazep | 2004 |
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Bipolar Disorder; Dopamine Antagonists; Double-Blind | 2005 |
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body W | 2005 |
Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Female | 2005 |
Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Efficiency; Female; Haloperidol; Hea | 2006 |
Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
Topics: Acute Disease; Adult; Allopurinol; Antimanic Agents; Basal Ganglia Diseases; Bipolar Disorder; Doubl | 2006 |
A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Brief Psychiat | 2007 |
Outcomes for Latin American versus White patients suffering from acute mania in a randomized, double-blind trial comparing olanzapine and haloperidol.
Topics: Acute Disease; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cholesterol; Diagnosti | 2007 |
Rapid tranquilization: a comparative study of thiothixene and haloperidol.
Topics: Adult; Bipolar Disorder; Brief Psychiatric Rating Scale; Female; Haloperidol; Humans; Injections, In | 1984 |
Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Th | 1984 |
Antimanic effect of clonazepam.
Topics: Acute Disease; Adult; Affective Disorders, Psychotic; Benzodiazepinones; Bipolar Disorder; Clonazepa | 1983 |
Haloperidol: a quarter century of experience.
Topics: Aged; Basal Ganglia Diseases; Bipolar Disorder; Clinical Trials as Topic; Dosage Forms; Drug Adminis | 1983 |
A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania.
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Drug Interactions; Drug Therapy, Combinatio | 1980 |
Flupenthixol versus haloperidol in acute psychosis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anxiety Disorders; Bipolar Disorder; Female; Flupenthixol; H | 1983 |
[Flupenthixol versus haloperidol in acute psychotic episodes].
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Double-Blind Method; Flupenthixol; Haloper | 1982 |
Lithium combined with carbamazepine or haloperidol in the treatment of mania.
Topics: Adult; Aged; Bipolar Disorder; Brief Psychiatric Rating Scale; Carbamazepine; Drug Combinations; Fem | 1995 |
Dosage of haloperidol for mania.
Topics: Adult; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Ind | 1994 |
Rapid tranquilization with intramuscular clonazepam.
Topics: Adult; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Adm | 1994 |
A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
Topics: Adolescent; Adult; Arousal; Bipolar Disorder; Clonazepam; Double-Blind Method; Drug Therapy, Combina | 1993 |
A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
Topics: Acute Disease; Administration, Oral; Adult; Basal Ganglia Diseases; Bipolar Disorder; Haloperidol; H | 1996 |
Lithium and haloperidol treatments differently affect the mononuclear leukocyte Galphas protein levels in bipolar affective disorder.
Topics: Adult; Aged; Animals; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Blotting, Western; C | 1999 |
Acute mania: haloperidol dose and augmentation with lithium or lorazepam.
Topics: Adult; Aged; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Citrates | 1999 |
Phenytoin as an antimanic anticonvulsant: a controlled study.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Brief Psychiatric Rating Scale; Double-Blind Me | 2000 |
Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
Topics: Acute Disease; Administration, Oral; Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder | 2000 |
Pretreatment plasma HVA and haloperidol response in acute mania.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug | 2000 |
A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Female; Hal | 2001 |
Haloperidol blood levels in acute mania with psychosis.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Female; Haloperidol; Humans; Male; Middle Aged; | 2001 |
Adjunctive antipsychotic treatment is necessary for adolescents with psychotic mania.
Topics: Acute Disease; Adolescent; Age Factors; Bipolar Disorder; Child; Double-Blind Method; Drug Therapy, | 2001 |
Olanzapine versus haloperidol in schizoaffective disorder, bipolar type.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind M | 2001 |
The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relatio | 2002 |
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents | 2002 |
Lithium in the treatment of mania: comparisons with neuroleptics.
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Dose-Response Rela | 1979 |
Droperidol in acutely agitated patients. A double-blind placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Clinical Trials as Topic; Droperidol; Drug | 1977 |
Therapeutic effects of carbamazepine in affective illness: a preliminary report.
Topics: Adult; Affective Symptoms; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depression; Do | 1978 |
Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol.
Topics: Acute Disease; Administration, Oral; Basal Ganglia Diseases; Bipolar Disorder; Clinical Trials as To | 1979 |
Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study.
Topics: Adult; Bipolar Disorder; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; F | 1979 |
Acute high-dose parenteral haloperidol treatment of psychosis.
Topics: Acute Disease; Adult; Bipolar Disorder; Blood Pressure; Clinical Trials as Topic; Diazepam; Dose-Res | 1979 |
Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol.
Topics: Adult; Aged; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Female; Haloperidol; Humans | 1975 |
Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
Topics: Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Creatine Kinase; Female; Follow-Up Stu | 1992 |
Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
Topics: Adult; Aged; Aggression; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; H | 1992 |
Dose and blood levels of haloperidol in treatment of mania.
Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Male; Middle Aged | 1990 |
Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, | 1989 |
Carbamazepine compared to haloperidol in acute mania.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Chlor | 1989 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ga | 1988 |
Clonazepam in acute and maintenance treatment of bipolar affective disorder.
Topics: Acute Disease; Adult; Bipolar Disorder; Clinical Trials as Topic; Clonazepam; Double-Blind Method; D | 1987 |
Rapid cycling disorders and the role of combined lithium and haloperidol decanoate.
Topics: Bipolar Disorder; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Haloperidol; | 1986 |
[Carbamazepine in manic syndromes. A controlled double-blind study].
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Th | 1985 |
The current status of lithium in psychiatry.
Topics: Acute Disease; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Depression; Female; Halop | 1974 |
European experiences with haloperidol.
Topics: Bipolar Disorder; Clinical Trials as Topic; Haloperidol; Humans; Schizophrenia | 1967 |
Prospective clinical applications of haloperidol.
Topics: Bipolar Disorder; Clinical Trials as Topic; Haloperidol; Humans; Lithium; Phenothiazines; Schizophre | 1967 |
Long term haloperidol therapy in outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Bipolar Disorder; Clinical Trials as Topic; Depressive Dis | 1967 |
[Clinical experimentation with desipramine with statistical control].
Topics: Adult; Aged; Anorexia Nervosa; Barbiturates; Bipolar Disorder; Chlordiazepoxide; Chlorpromazine; Cli | 1968 |
257 other studies available for haloperidol and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Asenapine: a novel psychopharmacologic agent with a unique human receptor signature.
Topics: Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Cloning, Molecular; Clozapine; Dibenzoc | 2009 |
Absconding among admitted patients with bipolar affective disorder diagnosis in Uganda.
Topics: Bipolar Disorder; Haloperidol; Hospitalization; Humans; Mood Disorders; Patient Dropouts; Retrospect | 2023 |
Hypertensive bipolar: chronic lithium toxicity in patients taking ACE inhibitor.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Bipolar Disorder; Delirium; Diagnosis | 2017 |
Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Comorbidity; Electroconvulsive | 2017 |
Study Enrollment When "Preconsent" Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Emergency Service, Hospital; Ethics, Research; Female | 2019 |
Prevalence and clinical presentation of HIV positive female psychiatric inpatients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Comorbidity; Cross-Sectional Studie | 2013 |
Experimental evidence for the involvement of PDLIM5 in mood disorders in hetero knockout mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Behavior, Animal; Bipolar Disorder; Brain; Cell Line; | 2013 |
The nesfatin 1 level in male patients with manic episode and alterations of nesfatin 1 level after antipsychotic and electroconvulsive treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Calcium-Binding Proteins; Case-Cont | 2013 |
Initial and post-treatment total oxidant-antioxidant status and oxidative stress index in male patients with manic episode.
Topics: Antioxidants; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Electroconvulsive Therapy; | 2014 |
Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder.
Topics: Animals; Atrophy; Bipolar Disorder; Case-Control Studies; Clozapine; Dendritic Spines; Female; Front | 2014 |
Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Case-Control Studies; Combined Modality Therapy; Elec | 2015 |
Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Electroconvulsive | 2015 |
SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Case-Control Studies; Chlorpromazine; Depressive Di | 2015 |
Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Cell Death; Cell Line, Tumor; Cell Survival; Halope | 2016 |
Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar Patients.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Female; Follow | 2015 |
[Acute Psychosis after Consumption of Synthetic Cannabinoids].
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cannabinoids; Hallucinations; Haloperidol; Humans; Hy | 2016 |
The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Female; Haloperidol; Humans; Male; O | 2016 |
An unusual cause of cervical kyphosis.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cervical Vertebrae; Female; Haloperidol; Humans; Kyph | 2017 |
Bipolar disorder, homocysteine and white matter hyperintensities.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Brain; Female; Folic Acid; Haloperidol; Ho | 2008 |
Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiaze | 2009 |
2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease.
Topics: Adult; Analysis of Variance; Animals; Bipolar Disorder; Brain; Case-Control Studies; Chromatography, | 2009 |
Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
Topics: Adult; Aged; Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; | 2009 |
The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
Topics: Adult; Alleles; Antipsychotic Agents; Bipolar Disorder; Clozapine; Cytochrome P-450 CYP2D6; Dibenzot | 2010 |
A report from the 4th biennial conference of the international society of bipolar disorder (March 17-20, 2010 - Sao Paulo, Brazil).
Topics: Bipolar Disorder; Brazil; Citalopram; Dopamine Antagonists; Haloperidol; Humans; Selective Serotonin | 2010 |
Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Cultural Characteristics; Disease Progres | 2011 |
Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.
Topics: Adult; Animals; Antipsychotic Agents; Bipolar Disorder; Blotting, Western; Clathrin; Electrophoresis | 2011 |
Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bundle-Branch Block; Combined Modality T | 2011 |
Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Brain; Haloperidol; Lithium Compounds; Magnetic Res | 2012 |
Haloperidol induced obsessive compulsive symptom (OCS) in a patient with learning disability and bipolar affective disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Diagnosis, Differential; Haloperidol; Humans; Learnin | 2012 |
A larval zebrafish model of bipolar disorder as a screening platform for neuro-therapeutics.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Bipolar Disorder; Dark Ada | 2012 |
Coexistence and independence between a mental disorder and female stalking.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Commitment of Mentally Ill; Dibenzo | 2013 |
AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment.
Topics: A Kinase Anchor Proteins; Adult; Antipsychotic Agents; Bipolar Disorder; Calcium Channels; Drug Resi | 2013 |
Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Hypnotic | 2013 |
Quetiapine-associated and dose-related hypomania in a woman with schizophrenia.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Diazepam; Dibenzothiazepines; Dose-Response Relations | 2002 |
Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Blotting, Western; Cell Count; Contractile Proteins | 2003 |
[Haloperidol in states of manic excitation (apropos of 10 cases)].
Topics: Anesthesia; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Psycho | 1961 |
[Clinical tests with haldol in long-term schizophrenia and acute manic states].
Topics: Anesthesia; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Psycho | 1961 |
The treatment of mania with Haloperidol ('Serenace').
Topics: Anesthesia; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Psycho | 1962 |
PSYCHOMOTOR ASSESSMENT OF THE EFFECTS OF HALOPERIDOL.
Topics: Bipolar Disorder; Haloperidol; Kinesthesis; Motor Skills; Parkinsonian Disorders; Psychotic Disorder | 1963 |
THE USE OF HALOPERIDOL (SERENASE (R)) IN CHLORPROTIXEN RESISTANT PATIENTS.
Topics: Accommodation, Ocular; Adolescent; Antisocial Personality Disorder; Bipolar Disorder; Chlorprothixen | 1963 |
[OUR EXPERIENCES WITH A NEW MAJOR NEUROLEPTIC: HALOPERIDOL].
Topics: Antipsychotic Agents; Bipolar Disorder; Epilepsy; Haloperidol; Humans; Mental Disorders; Psychoses, | 1963 |
POTENTIATION OF PHARMACOLOGICAL AND THERAPEUTIC ACTION OF PHENOTHIAZINES BY NYLIDRIN (ARLIDIN).
Topics: Bipolar Disorder; Brain; Brain Damage, Chronic; Chlorprothixene; Depressive Disorder, Major; Dextran | 1964 |
[THE TREATMENT OF MANIAS AND MANIC STATES WITH HALOPERIDOL].
Topics: Bipolar Disorder; Haloperidol; Humans; Mental Disorders; Psychotic Disorders | 1964 |
[CLINICAL EXPERIENCES WITH HALOPERIDOL (SERENASE)].
Topics: Bipolar Disorder; Chlorpromazine; Chorea; Dementia; Depressive Disorder, Major; Epilepsy; Haloperido | 1964 |
DEPRESSIVE AND MANIC PSYCHOSES AND ALLIED DISORDERS.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Barbiturates; Bipolar Disorder; Depression; Electr | 1964 |
[HUNTINGTON'S CHOREA, HUMOR DISORDERS WITH MANIC MANIFESTATIONS, BENEFICIAL EFFECTS OF HALOPERIDOL (FLUOROPHENYLPIPERIDINOBUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
Topics: Bipolar Disorder; Chlorpromazine; Chorea; Electroencephalography; Electromyography; Haloperidol; Hum | 1964 |
[COGENTINE (BTMS) IN THE TREATMENT OF NEUROLEPTIC SYNDROMES].
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Delirium; Depression; Hallucinations; Halope | 1964 |
[EFFECT OF DRUG THERAPY ON REHOSPITALIZATIONS AT THE BEL AIR CLINIC OF PATIENTS WITH CHRONIC PSYCHOSES EXCEPT MANIC-DEPRESSIVE PSYCHOSES].
Topics: Bipolar Disorder; Chlorpromazine; Chlorprothixene; Convulsive Therapy; Drug Therapy; Haloperidol; Ho | 1964 |
[TREATMENT OF CHRONIC PSYCHOSES WITH HALOPERIDOL (R 1625)].
Topics: Bipolar Disorder; Drug Therapy; Haloperidol; Humans; Mental Disorders; Movement Disorders; Psychotic | 1964 |
[HUNTINGTON'S CHOREA, TEMPERAMENT DISORDERS OF MANIAC EXPRESSION. BENEFICIAL EFFECTS OF HALOPERIDOL (FLUORO-PHENYL-PIPERIDINE BUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
Topics: Bipolar Disorder; Butyrophenones; Chorea; Drug Therapy; Electromyography; Haloperidol; Humans; Hunti | 1964 |
CHANGES IN SERUM PROTEINS AND CEREBROSPINAL FLUID PROTEINS DURING PHARMACOTHERAPY OF PSYCHOSES.
Topics: Alcoholism; Bipolar Disorder; Blood Proteins; Cerebrospinal Fluid Proteins; Chlorpromazine; Drug The | 1964 |
[SOMATOTHERAPY OF ENDOGENOUS PSYCHOSES AT MARBURG UNIVERSITY NEUROLOGIC CLINIC].
Topics: Bipolar Disorder; Chlordiazepoxide; Chlorpromazine; Chlorprothixene; Convulsive Therapy; Depression; | 1964 |
[Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical T | 2003 |
Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
Topics: Adolescent; Aggression; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorde | 2003 |
Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Antiviral Agents; Bipolar Disorder; Dose-Response Rel | 2004 |
Olanzapine: new indication. New indication in acute mania: just another neuroleptic.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; France; Haloperidol; | 2004 |
A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses.
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Chromosomes, Human, Pair 12; Comorbidity; Ge | 2004 |
Olanzapine for injection: new formulation. No advantage in agitated patients.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; France; Haloperidol; | 2004 |
A mood stabilizer with risperidone or haloperidol for mania.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combinat | 2004 |
A mood stabilizer with risperidone or haloperidol for mania.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combinat | 2004 |
Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol.
Topics: Acute Disease; Adult; Antimanic Agents; Bipolar Disorder; Chlorpromazine; Diabetic Ketoacidosis; Dia | 2004 |
Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode.
Topics: Acute Disease; Antipsychotic Agents; Bipolar Disorder; Clinical Trials Data Monitoring Committees; D | 2005 |
Improvement in tardive dyskinesia with aripiprazole use.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; | 2005 |
A blessing in disguise: resolution of tardive dyskinesia with development of cervical myelitis.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cervical Vertebrae; Dyskinesia, Drug-Induced; Follow- | 2006 |
An unusual case of subterfuge in the emergency department: covert administration of antipsychotic and anxiolytic medications to control an agitated patient.
Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Beverages; Bipolar Disorder; | 2006 |
Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics.
Topics: Adolescent; Adult; Antipsychotic Agents; Binding, Competitive; Bipolar Disorder; Blood Platelets; Fe | 2006 |
Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Creatine Kinase; Diagnosis, Differen | 2006 |
Classical mania associated with dengue infection.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Dengue; Haloperidol; Humans; India; Ma | 2006 |
Epileptic seizures superimposed on catatonic stupor.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Catatonia; Combined Modality Therapy; | 2006 |
Efficacy of olanzapine and haloperidol in an animal model of mania.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Bipolar Diso | 2006 |
Anabolic androgenic steroid abuse and mood disorder: a case report.
Topics: Adult; Anabolic Agents; Antipsychotic Agents; Bipolar Disorder; Haloperidol; Humans; Impulsive Behav | 2007 |
Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Topics: Adult; Akathisia, Drug-Induced; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Basal Gangl | 2006 |
Drug-induced Brugada syndrome with ST-T wave alternans and long QT.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Arrhythmias, Cardiac; | 2007 |
[Fludrocortisone resistance in a patient with Addison disease and bipolar disorder treated with lithium].
Topics: Addison Disease; Adrenocorticotropic Hormone; Adult; Bipolar Disorder; Drug Interactions; Drug Resis | 2007 |
Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Drug A | 2008 |
Intramuscular aripiprazole in the control of agitation.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Arousal; Bipolar Disorder; Dose-Response Relationship, Dr | 2007 |
Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.
Topics: Adult; Animals; Arrestins; Autopsy; beta-Arrestins; Bipolar Disorder; Case-Control Studies; Cell Lin | 2008 |
Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clonazepam; Dose-Resp | 2007 |
Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Da | 2007 |
Treatment of mania in the last six months of pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Antipsychotic Agents; Bipolar Disorder; Female; Haloperidol; Hum | 1980 |
New data on lithium and haloperidol incompatibility.
Topics: Antipsychotic Agents; Bipolar Disorder; Drug Incompatibility; Drug Therapy, Combination; Dyskinesia, | 1981 |
Treatment of neuroleptic malignant syndrome with dantrolene.
Topics: Adult; Bipolar Disorder; Dantrolene; Haloperidol; Humans; Male; Malignant Hyperthermia; Muscle Rigid | 1982 |
Mania: diagnosis and treatment.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Antiparkinson Agents; Antipsychotic Agents; Bipol | 1982 |
[Long-term use of 200 mg Dogmatil. Apropos of 13 cases].
Topics: Adult; Amitriptyline; Antipsychotic Agents; Bipolar Disorder; Borderline Personality Disorder; Drug | 1984 |
Dissimilar dosing with high-potency and low-potency neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Drug Utilization; F | 1984 |
Case report of a possible interaction between neuroleptics and carbamazepine.
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Delirium; Drug Interactions; Female; Haloperi | 1984 |
Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Delayed-Action Preparations; Female; Haloperidol; Hum | 1984 |
Secondary mania associated with sympathomimetic drug use.
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Bronchodilator Agents; Female; Haloperidol; | 1981 |
A possible neurochemical basis for the neuropsychiatric aspects of baclofen therapy.
Topics: Adult; Baclofen; Bipolar Disorder; Brain; Delusions; Depressive Disorder; Dose-Response Relationship | 1983 |
Lithium interferes with reserpine-induced dopamine depletion.
Topics: Adult; Animals; Bipolar Disorder; Corpus Striatum; Dopamine; Dopamine Antagonists; Dyskinesia, Drug- | 1983 |
Toxic irreversible encephalopathy induced by lithium carbonate and haloperidol. A report of 2 cases.
Topics: Adult; Bipolar Disorder; Brain Diseases; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female | 1983 |
The effect of haloperidol on serum levels of lithium in adult manic patients.
Topics: Adolescent; Adult; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Female; Haloperid | 1984 |
Development of tolerance to the therapeutic effect of amantadine on akathisia.
Topics: Adult; Akathisia, Drug-Induced; Amantadine; Bipolar Disorder; Drug Tolerance; Female; Haloperidol; H | 1984 |
Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia.
Topics: Administration, Oral; Adolescent; Adult; Bipolar Disorder; Dose-Response Relationship, Drug; Female; | 1984 |
Early onset of severe dyskinesia following lithium-haloperidol treatment.
Topics: Adult; Bipolar Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; L | 1983 |
Effect of combined haloperidol-lithium treatment on vitro RBC lithium uptake in patients with affective disorders.
Topics: Bipolar Disorder; Drug Therapy, Combination; Erythrocytes; Haloperidol; Humans; Lithium; Psychotic D | 1983 |
The use of depot neuroleptic haloperidol decanoate.
Topics: Bipolar Disorder; Depressive Disorder; Haloperidol; Humans; Prognosis; Psychotic Disorders; Schizoph | 1984 |
Disturbances of thirst and water homeostasis in patients with affective illness.
Topics: Acute Disease; Adult; Aged; Bipolar Disorder; Drinking Behavior; Female; Haloperidol; Humans; Hypona | 1984 |
High-performance liquid chromatography of haloperidol in serum at the concentrations achieved during chronic therapy.
Topics: Bipolar Disorder; Chromatography, High Pressure Liquid; Chronic Disease; Haloperidol; Humans; Kineti | 1984 |
Untoward effects following combined neuroleptic-lithium therapy. Cardiac arrhythmias and seizure.
Topics: Adult; Arrhythmias, Cardiac; Bipolar Disorder; Chlorpromazine; Drug Therapy, Combination; Epilepsy, | 1980 |
Persistent dysarthria with apraxia associated with a combination of lithium carbonate and haloperidol.
Topics: Adult; Apraxias; Bipolar Disorder; Drug Therapy, Combination; Dysarthria; Haloperidol; Humans; Lithi | 1982 |
The relationship between prolactin levels and clinical ratings in manic patients treated with oral and intravenous test doses of haloperidol.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Bipolar Disorder; Female; Haloperidol; Humans; In | 1983 |
Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients.
Topics: Adolescent; Adult; Bipolar Disorder; Blood Pressure; Dextroamphetamine; Emotions; Female; Growth Hor | 1982 |
Mania responsive to lecithin in a 13-year-old girl.
Topics: Adolescent; Bipolar Disorder; Child; Female; Haloperidol; Hospitalization; Humans; Lithium; Phosphat | 1982 |
Questions about combined lithium and haloperidol treatment.
Topics: Bipolar Disorder; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Male | 1982 |
Relapse in patients with shifting RDC diagnoses treated with lithium alone.
Topics: Adult; Bipolar Disorder; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Ha | 1982 |
Prolactin response to neuroleptic challenge.
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Haloperidol; Humans; Prolactin | 1982 |
Mania-induced remission of tardive dyskinesia in manic-depressive illness.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Remiss | 1982 |
Pain insensitivity in psychosis.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Diagnosis, Differential; Duodenal Ulcer; Female; Haloperido | 1982 |
The impact of long-time, low-dosage haloperidol therapy on anxiety proneness.
Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Male; Stuttering | 1981 |
[Treatment of outpatients with high doses of haloperidol].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antiparkinson Agents; Basal Ganglia Diseases; Bipolar Diso | 1981 |
Treatment of lithium/neuroleptic neurotoxicity during lithium maintenance.
Topics: Bipolar Disorder; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Middle Aged; Nerv | 1980 |
Case report: manic depressive psychosis following infectious mononucleosis.
Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Infectious Mononucleosis; Lithium | 1980 |
Personality in unipolar and bipolar manic-malancholic patients.
Topics: Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; F | 1980 |
Trichotillomania: symptom or syndrome? A need for revision.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cultural Characteristics; Delusions; Drug Therapy, Co | 1995 |
In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
Topics: Adult; Bipolar Disorder; Brain; Carbon Radioisotopes; Caudate Nucleus; Female; Haloperidol; Humans; | 1995 |
Canny cases. Case 4: A precipitate poisoning.
Topics: Administration, Oral; Adult; Beverages; Biological Availability; Bipolar Disorder; Chemical Precipit | 1995 |
Rapid resolution of first episodes of mania: sleep related?
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Combined Modality Therapy; Female; Haloperidol; Human | 1994 |
Neuroleptic malignant syndrome and catatonia. A report of three cases.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Depressive Disorder; Dibenzothiazepines; D | 1994 |
Overflow movements may predict neuroleptic-induced dystonia.
Topics: Adolescent; Adult; Bipolar Disorder; Dyskinesia, Drug-Induced; Dystonia; Haloperidol; Humans; Male; | 1994 |
Lethal catatonia and neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Diagnosis, Differential; Dose-Response Rel | 1993 |
Mania following sleep deprivation.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Haloperidol; Humans; Male; Sleep Deprivation | 1993 |
Reduced total complement haemolytic activity in schizophrenic patients.
Topics: Autoimmune Diseases; Bipolar Disorder; Chronic Disease; Complement Activation; Complement C3; Comple | 1993 |
Acutely psychotic patients receiving high-dose haloperidol therapy.
Topics: Acute Disease; Adolescent; Adult; Bipolar Disorder; Crisis Intervention; Dose-Response Relationship, | 1993 |
Acute manic episodes in pregnancy.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Comorbidity; Diabetes Mellitus, Type 1; Drug Therapy, Combi | 1996 |
Prolonged neurological sequelae after combination treatment with lithium and antipsychotic drugs.
Topics: Adult; Akathisia, Drug-Induced; Anti-Dyskinesia Agents; Antidepressive Agents; Bipolar Disorder; Dia | 1996 |
Catheter-associated central venous thrombosis.
Topics: Adult; Bipolar Disorder; Catheterization, Central Venous; Dantrolene; Female; Fluid Therapy; Haloper | 1996 |
Plasma haloperidol and reduced haloperidol concentrations in a geriatric population.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Dementia; Dose- | 1996 |
Bipolar disorder following a stroke involving the left hemisphere.
Topics: Bipolar Disorder; Cerebral Infarction; Dominance, Cerebral; Drug Therapy, Combination; Haloperidol; | 1996 |
Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Dipeptidy | 1996 |
Comparison of therapeutic modalities for mania.
Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Lithium; Male; Psychiatric Status Rating Scale | 1996 |
A patient with mania and photoconvulsive epilepsy.
Topics: Adolescent; Anticonvulsants; Bipolar Disorder; Brain; Carbamazepine; Drug Therapy, Combination; Elec | 1996 |
Akathisia as violence.
Topics: Akathisia, Drug-Induced; Bipolar Disorder; Diagnosis, Differential; Haloperidol; Humans; Male; Middl | 1997 |
Manic episodes in two patients treated with interferon alpha.
Topics: Adult; Bipolar Disorder; Clonazepam; Cognition Disorders; Dopamine Antagonists; Female; GABA Modulat | 1997 |
[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benperidol; Benzamides; Bipolar Disorder; | 1997 |
Psychosis following acute alteration of thyroid status.
Topics: Adult; Antithyroid Agents; Bipolar Disorder; Combined Modality Therapy; Diagnosis, Differential; Gra | 1997 |
Clinical predictors of acute response with olanzapine in psychotic mood disorders.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age Factors; Antipsychotic Agents; Benzodiazepine | 1998 |
Pretreatment plasma HVA predicts neuroleptic response in manic psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Female; Haloperidol; Homovanillic Acid; H | 1998 |
Belief in transmigration of the soul and psychopathology in Israeli Druze. A culture-sensitive psychotherapeutic approach.
Topics: Adult; Bipolar Disorder; Combined Modality Therapy; Conversion Disorder; Culture; Haloperidol; Human | 1998 |
Topographic EEG studies of mania.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; Halope | 1998 |
Clarithromycin-induced mania.
Topics: Bipolar Disorder; Clarithromycin; Depressive Disorder; Female; Haloperidol; Humans; Lithium; Middle | 1998 |
Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Delirium; Dyskinesia, Drug-Induced; Female | 1998 |
Medical management of disturbed behaviour.
Topics: Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Chlorpromazine; Depressive Disorder; Dysto | 1998 |
Mania onset while using dehydroepiandrosterone.
Topics: Acute Disease; Bipolar Disorder; Dehydroepiandrosterone; Drug Therapy, Combination; Haloperidol; Hum | 1999 |
Treatment of acute mania with topiramate.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug A | 1999 |
Lamotrigine-induced rash after sun exposure.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Drug Eruptions; Drug Therapy, Combination; Female; Haloper | 1999 |
Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Drug Admini | 1999 |
Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients.
Topics: Adolescent; Adult; Aged; Animals; Antipsychotic Agents; Bipolar Disorder; Brain; Depressive Disorder | 2000 |
Dimensionality, responsiveness and standardization of the Bech-Rafaelsen Mania Scale in the ultra-short therapy with antipsychotics in patients with severe manic episodes.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Clopenthixol; Female; Haloperidol; Hum | 2001 |
Tetraspan protein CD151: a common target of mood stabilizing drugs?
Topics: Affect; Amino Acid Sequence; Animals; Antigens, CD; Antipsychotic Agents; Bipolar Disorder; Blotting | 2001 |
[Manic syndrome: diagnostic trends and principles of treatment].
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chl | 1998 |
Cerebellar ataxia with intravenous valproate and haloperidol.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cerebellar Ataxia; Haloperidol; Hum | 2002 |
Drugs for psychiatric disorders.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; | 1976 |
Comparison of the therapeutic effect of lithium and neuroleptic treatment (haloperidol, octoclothepin, oxyprothepin) in mania patients [proceedings].
Topics: Adult; Bipolar Disorder; Dibenzothiepins; Female; Haloperidol; Humans; Lithium; Male | 1976 |
Sedative, hypnotic, and antipsychotic effects of low doses of apomorphine in man.
Topics: Adolescent; Adult; Antipsychotic Agents; Apomorphine; Bipolar Disorder; Drug Interactions; Female; H | 1977 |
Juvenile manic-depressive illness.
Topics: Adolescent; Affective Symptoms; Antipsychotic Agents; Bipolar Disorder; Child Behavior Disorders; Er | 1977 |
[Incompatibility of lithium therapy with neuroleptics. a case report (author's transl)].
Topics: Antipsychotic Agents; Bipolar Disorder; Drug Interactions; Female; Flupenthixol; Haloperidol; Humans | 1979 |
Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Drug Therapy, Combination | 1979 |
Toxic reactions to lithium and haloperidol.
Topics: Adolescent; Adult; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug- | 1976 |
Cardiac arrhythmia and haloperidol.
Topics: Adult; Arrhythmias, Cardiac; Bipolar Disorder; Blood Pressure; Cardiac Complexes, Premature; Haloper | 1979 |
Thyrotrophin-releasing hormone (TRH) stimulation test in manic-depressive illness.
Topics: Adjustment Disorders; Adult; Age Factors; Aged; Biperiden; Bipolar Disorder; Depression; Female; Hal | 1978 |
Mode of action of lithium: some biological considerations.
Topics: Animals; Apomorphine; Bipolar Disorder; Brain; Carrier Proteins; Cyclic AMP; Dopamine; Haloperidol; | 1979 |
[Dangerous side effects of lithium therapy].
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Brain Stem; Delirium; Diabetes Insipidus; D | 1977 |
Emergency use of intravenous haloperidol.
Topics: Adult; Bipolar Disorder; Emergency Services, Psychiatric; Female; Hallucinations; Haloperidol; Human | 1979 |
Electrooculographic (EOG) findings in manic-depressive illness.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Bipolar Disorder; Electrooculography; Eye Movem | 1979 |
[Lithium-intoxication masked by neuroleptic drugs in the lithium--saluretic combination (author's transl)].
Topics: Bipolar Disorder; Delusions; Drug Interactions; Haloperidol; Humans; Lithium; Male; Middle Aged; Tre | 1977 |
[A case of lithium intoxication at therapeutic lithium dosage due to additional diuretic therapy (author's transl)].
Topics: Amiloride; Bipolar Disorder; Drug Combinations; Drug Interactions; Haloperidol; Humans; Hydrochlorot | 1978 |
Questions about rapid treatment.
Topics: Acute Disease; Bipolar Disorder; Emergency Service, Hospital; Female; Haloperidol; Humans; Psychotic | 1977 |
Concomitant administration of haloperidol and lithium carbonate in acute mania.
Topics: Acute Disease; Adolescent; Adult; Bipolar Disorder; Drug Therapy, Combination; Haloperidol; Humans; | 1977 |
[Usefulness for differential diagnosis of the distribution of extrapyramidal symptoms resulting from neuroleptic therapy in psychiatric practice].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Diagnosis, Differential; Female; Functional Lateral | 1976 |
[Chemotherapy of melancholia by sequential neuroleptic-viloxazine association].
Topics: Adjustment Disorders; Adult; Bipolar Disorder; Chlorpromazine; Depression; Depressive Disorder, Majo | 1976 |
Adverse reactions in treatment with lithium carbonate and haloperidol.
Topics: Affective Symptoms; Bipolar Disorder; Drug Synergism; Female; Fever; Haloperidol; Humans; Lithium; M | 1976 |
A case of manic-depressive illness in childhood.
Topics: Adolescent; Age Factors; Alberta; Bipolar Disorder; Child; Chlorpromazine; Doxepin; Electroconvulsiv | 1975 |
Models of mania: An individual case study.
Topics: Adult; Bipolar Disorder; Electric Conductivity; Haloperidol; Heart Rate; Humans; Light; Lithium; Mal | 1975 |
Treatment of neuroleptic-resistant mania and schizoaffective disorders.
Topics: Antipsychotic Agents; Bipolar Disorder; Drug Synergism; Drug Therapy, Combination; Haloperidol; Huma | 1992 |
Treatment of hypomania following neuroleptic malignant syndrome.
Topics: Adult; Arousal; Bipolar Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Haloperidol; | 1992 |
Functional brain asymmetry and visuospatial perception in mania, depression, and psychotropic medication.
Topics: Adult; Bipolar Disorder; Brain; Chlorpromazine; Depressive Disorder; Female; Functional Laterality; | 1992 |
Cycloid psychosis: regional cerebral blood flow correlates of a psychotic episode.
Topics: Adult; Aged; Bipolar Disorder; Blood Flow Velocity; Cerebral Cortex; Chlorpromazine; Dominance, Cere | 1992 |
Drug-responsive symptoms during early neuroleptic treatment.
Topics: Adult; Benztropine; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Th | 1992 |
Peripheral neuropathy as a complication of neuroleptic malignant syndrome.
Topics: Adult; Axons; Bipolar Disorder; Electromyography; Female; Haloperidol; Humans; Neuroleptic Malignant | 1991 |
Red blood cell NMR proton relaxation times in ill and recovered patients with unipolar and bipolar affective disorders.
Topics: Bipolar Disorder; Chlorpromazine; Depressive Disorder; Erythrocytes; Female; Haloperidol; Humans; In | 1991 |
Cold agglutinin autoantibodies in psychiatric patients: their relation to diagnosis and pharmacological treatment.
Topics: Adult; Age Factors; Agglutinins; Autoantibodies; Bipolar Disorder; Cryoglobulins; Depressive Disorde | 1991 |
The course of a seasonal bipolar disorder influenced by caffeine.
Topics: Bipolar Disorder; Caffeine; Chlorpromazine; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 1991 |
Haloperidol and lithium carbonate treatment did not influence serum immunoglobulin levels in schizophrenic and affective patients.
Topics: Adolescent; Adult; Bipolar Disorder; Chronic Disease; Depressive Disorder; Female; Haloperidol; Huma | 1991 |
Idiopathic edema.
Topics: Adult; Bipolar Disorder; Drug Therapy, Combination; Edema; Female; Haloperidol; Humans; Lithium; Rec | 1991 |
Psychotogenic drug use and neuroleptic response.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Haloperidol; Homovan | 1990 |
Psychotogenic drug use and neuroleptic response.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Haloperidol; Homovan | 1990 |
Psychotogenic drug use and neuroleptic response.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Haloperidol; Homovan | 1990 |
Psychotogenic drug use and neuroleptic response.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Haloperidol; Homovan | 1990 |
Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug | 1990 |
Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism.
Topics: Adult; Bipolar Disorder; Blood Pressure; Depressive Disorder; Down-Regulation; Feedback; Female; Hal | 1990 |
Inositol-1-phosphatase in red blood cells of manic-depressive patients before and during treatment with lithium.
Topics: Adult; Bipolar Disorder; Erythrocytes; Haloperidol; Humans; Lithium; Middle Aged; Phosphoric Monoest | 1990 |
Combined neuroleptic malignant syndrome and the central anticholinergic syndrome.
Topics: Adult; Benztropine; Bipolar Disorder; Coma; Diagnosis, Differential; Drug Therapy, Combination; Halo | 1990 |
Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
Topics: Adult; Bipolar Disorder; Haloperidol; Humans; Male; Prolactin; Psychiatric Status Rating Scales; Psy | 1990 |
Rapid cycling following antidepressant in an adolescent.
Topics: Adolescent; Bipolar Disorder; Clonazepam; Dibenzazepines; Drug Administration Schedule; Drug Therapy | 1990 |
Electroencephalographic changes and other indices of neurotoxicity with haloperidol-lithium therapy.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Brain; Dyskinesia, Drug-Induced; Electroencephalograp | 1989 |
Effect of lithium and neuroleptic combination on lithium transport, blood pressure, and weight in bipolar patients.
Topics: Adult; Aged; Bipolar Disorder; Blood Pressure; Body Weight; Chlorpromazine; Dose-Response Relationsh | 1989 |
Transmembrane lithium distribution and hypertension in manic depressive patients.
Topics: Adult; Bipolar Disorder; Blood Pressure; Chlorpromazine; Drug Therapy, Combination; Erythrocytes; Fe | 1989 |
Neuroleptic malignant syndrome with hypomania and mental retardation.
Topics: Adult; Bipolar Disorder; Diagnosis, Differential; Haloperidol; Hepatitis B; Humans; Intellectual Dis | 1989 |
Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine.
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Femal | 1989 |
Hepatotoxicity following treatment with bromperidol.
Topics: Adult; Bipolar Disorder; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; | 1989 |
Haloperidol decanoate.
Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Patient Compliance; Schizophrenia; Schizophren | 1989 |
Mania associated with small cell carcinoma of the lung.
Topics: ACTH Syndrome, Ectopic; Aged; Bipolar Disorder; Carcinoma, Small Cell; Female; Haloperidol; Humans; | 1988 |
Acutely psychotic patients: a treatment approach.
Topics: Acute Disease; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Combined Modality Therapy; Do | 1985 |
Treatment of rapid cycling affective illness.
Topics: Antipsychotic Agents; Bipolar Disorder; Haloperidol; Humans | 1985 |
Safety of the combination of lithium and neuroleptic drugs.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Female; | 1986 |
Correlation of neuroleptic dose and neurotoxicity in patients given lithium and a neuroleptic.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; D | 1987 |
Visual contrast sensitivity in drug-induced Parkinsonism.
Topics: Adolescent; Adult; Bipolar Disorder; Depressive Disorder; Drug Therapy, Combination; Female; Fluspir | 1989 |
Lithium-induced downbeat nystagmus.
Topics: Adult; Bipolar Disorder; Electrooculography; Female; Haloperidol; Humans; Lithium; Middle Aged; Nyst | 1988 |
Secondary mania from cerebral embolization with nonfocal neurologic findings.
Topics: Adult; Bipolar Disorder; Electroencephalography; Haloperidol; Humans; Intracranial Embolism and Thro | 1988 |
Prescribing lithium for pregnant women.
Topics: Adult; Bipolar Disorder; Carbamazepine; Female; Gestational Age; Haloperidol; Humans; Infant, Newbor | 1988 |
An interaction between haloperidol and carbamazepine in a patient with cerebral palsy.
Topics: Adult; Bipolar Disorder; Carbamazepine; Cerebral Palsy; Diabetes Mellitus, Type 1; Dose-Response Rel | 1987 |
Depot neuroleptics and manic depressive psychosis.
Topics: Adolescent; Adult; Bipolar Disorder; Delayed-Action Preparations; Female; Haloperidol; Humans; Male; | 1986 |
Neuroleptic malignant syndrome.
Topics: Bipolar Disorder; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome | 1986 |
[Mania of bereavement. Clinical characteristics and meaning].
Topics: Adult; Bipolar Disorder; Death; Grief; Haloperidol; Humans; Male; Methotrimeprazine; Psychopathology | 1987 |
Haloperidol as an alternative to lithium in pregnant women.
Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Lithium; Pregnancy; Pregnancy Complications | 1987 |
Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1986 |
Acute manic psychosis following the dermal application of N,N-diethyl-m-toluamide (DEET) in an adult.
Topics: Administration, Topical; Adult; Benzamides; Bipolar Disorder; DEET; Hallucinations; Haloperidol; Hot | 1986 |
Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
Topics: Basal Ganglia Diseases; Bipolar Disorder; Dantrolene; Drug Therapy, Combination; Haloperidol; Humans | 1985 |
Effect of haloperidol on sleep apnea.
Topics: Administration, Oral; Adult; Bipolar Disorder; Drug Therapy, Combination; Haloperidol; Humans; Lithi | 1985 |
Affective disorder in an adolescent.
Topics: Adolescent; Bipolar Disorder; Diagnosis, Differential; Female; Haloperidol; Humans; Lithium; Lithium | 1985 |
Effect of carbamazepine on neuroleptic plasma levels and efficacy.
Topics: Adult; Biological Availability; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; | 1986 |
Behavioral treatment in two cases of obsessive-compulsive disorder with concomitant bipolar affective disorder.
Topics: Adult; Behavior Therapy; Bipolar Disorder; Desipramine; Female; Haloperidol; Humans; Lithium; Male; | 1985 |
Iron pigment in the brain of a man with tardive dyskinesia.
Topics: Basal Ganglia; Bipolar Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gliosis; Halop | 1985 |
Catatonia in the emergency department.
Topics: Adult; Aged; Bipolar Disorder; Catatonia; Diagnosis, Differential; Emergency Service, Hospital; Halo | 1985 |
A haloperidol-carbamazepine interaction in a patient with rapid-cycling bipolar disorder.
Topics: Bipolar Disorder; Carbamazepine; Delirium; Drug Therapy, Combination; Female; Haloperidol; Humans; M | 1985 |
Persistent drug-induced parkinsonism.
Topics: Bipolar Disorder; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Risk | 1985 |
Plasma cortisol levels in mania: associated clinical ratings and changes during treatment with haloperidol.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Female; Haloperidol; Humans; Hydrocortisone; Male; Middle | 1985 |
The clinical use of psychotherapeutic drugs in the elderly.
Topics: Aged; Aging; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Benzodiazepi | 1974 |
Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Depression; Dih | 1974 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorprom | 1974 |
Prophylactic lithium: another therapeutic myth? An examination of the evidence to date.
Topics: Amitriptyline; Bipolar Disorder; Haloperidol; Humans; Imipramine; Lithium; Phenelzine; Trifluoperazi | 1968 |
Long-term effects of haloperidol.
Topics: Adolescent; Adult; Back Pain; Basal Ganglia Diseases; Bipolar Disorder; Depression; Depressive Disor | 1973 |
Role of central dopaminergic receptors in manic response of cats to morphine.
Topics: Animals; Atropine; Bipolar Disorder; Cats; Central Nervous System; Chlorpromazine; Dopamine; Drug An | 1972 |
To the incompatibility of haloperidol with lithium salts.
Topics: Adolescent; Bipolar Disorder; Drug Incompatibility; Drug Therapy, Combination; Female; Haloperidol; | 1974 |
Psychological testing in depressive illness. I. Psychomotor performance.
Topics: Adult; Bipolar Disorder; Depression; Diagnosis, Differential; Female; Haloperidol; Humans; Male; Mid | 1974 |
Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Bipolar Disorder; Brain; Chlorpromazine; Chromatography, Gas; Deuterium; Dopamin | 1974 |
Lithium carbonate, haloperidol, and irreversible brain damage.
Topics: Acute Disease; Adult; Bipolar Disorder; Brain; Brain Diseases; Carbonates; Chronic Disease; Consciou | 1974 |
Haloperidol.
Topics: Adult; Bipolar Disorder; Haloperidol; Humans; Male | 1972 |
Haloperidol: fifteen years of clinical experience.
Topics: Antiemetics; Basal Ganglia Diseases; Bipolar Disorder; Female; Haloperidol; Humans; Mental Disorders | 1972 |
Depression and mania associated with Kleine-Levin-Critchley syndrome.
Topics: Adolescent; Bipolar Disorder; Electroconvulsive Therapy; Electroencephalography; Female; Haloperidol | 1973 |
Letter: Haloperidol.
Topics: Adult; Bipolar Disorder; Haloperidol; Humans; Male; Personality Disorders | 1973 |
[Phasic depression and epilepsy. Two polar cases].
Topics: Adult; Bipolar Disorder; Chlorprothixene; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Ha | 1971 |
The incidence of depressive symptoms during recovery from hypomania.
Topics: Bipolar Disorder; Chlorpromazine; Convalescence; Depression; Follow-Up Studies; Haloperidol; Humans; | 1972 |
Psychosocial profiles and efficacy of lithium treatment.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Human | 1971 |
[A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
Topics: Aged; Bipolar Disorder; Chlorpromazine; Chronic Disease; Extrapyramidal Tracts; Female; Haloperidol; | 1969 |
[Developmental study on night sleep during episodes of manias or acute depressions].
Topics: Acute Disease; Adult; Bipolar Disorder; Chlorpromazine; Delirium; Electroencephalography; Female; Ha | 1969 |
[Depressive condition with electroencephalographic abnormalities--contribution to differential diagnosis of endogenous depression].
Topics: Adolescent; Adult; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Depression; Diagnosis, Di | 1969 |
Prophylactic haloperidol in incipient hypomania.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Female; Haloperidol; Humans; Male; Middle Aged; Outp | 1970 |
[A comparative evaluation of the effect of lithium carbonate, haloperidol and preparation IB-503 in the treatment of manic states].
Topics: Adult; Aged; Bipolar Disorder; Carbonates; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; | 1971 |
[A comparative study of the relationship betwen the period of time since the beginning of treatment and the effectiveness of haloperidol therapy of manic states].
Topics: Bipolar Disorder; Haloperidol; Humans; Time Factors | 1971 |
[Therapy of cyclothymic mania].
Topics: Bipolar Disorder; Butyrophenones; Chlorpromazine; Haloperidol; Humans | 1967 |
[Clinical experiences with butyrophenone benperidol].
Topics: Benperidol; Bipolar Disorder; Electroencephalography; Epilepsy; Female; Haloperidol; Humans; Male; P | 1967 |
Some observations on the use of lithium carbonate.
Topics: Acute Disease; Bipolar Disorder; Haloperidol; Humans; Imipramine; Lithium; Phenothiazines; Schizophr | 1968 |
Evaluation of a new antipsychotic agent--haloperidol (haldol).
Topics: Bipolar Disorder; Haloperidol; Humans; Mental Disorders; Schizophrenia | 1968 |
A two-year clinical experience with lithium.
Topics: Adult; Bipolar Disorder; Desipramine; Female; Follow-Up Studies; Haloperidol; Humans; Lithium; Male; | 1968 |
[On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
Topics: Adult; Aged; Bipolar Disorder; Catatonia; Child; Depression; Depressive Disorder, Major; Extrapyrami | 1968 |
[A case of chronic piperazine abuse].
Topics: Adult; Bipolar Disorder; Haloperidol; Humans; Male; Movement Disorders; Piperazines; Substance-Relat | 1965 |
[Haloperidol in the treatment of the maniacal syndrome].
Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Male; Middle Aged | 1966 |
[The treatment of mania with psychopharmaceutical agents other than lithium].
Topics: Bipolar Disorder; Haloperidol; Humans | 1966 |